JPH028271B2 - - Google Patents
Info
- Publication number
- JPH028271B2 JPH028271B2 JP58230705A JP23070583A JPH028271B2 JP H028271 B2 JPH028271 B2 JP H028271B2 JP 58230705 A JP58230705 A JP 58230705A JP 23070583 A JP23070583 A JP 23070583A JP H028271 B2 JPH028271 B2 JP H028271B2
- Authority
- JP
- Japan
- Prior art keywords
- latex particles
- latex
- diagnostic agent
- hydrophilic
- biologically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000004816 latex Substances 0.000 claims description 77
- 229920000126 latex Polymers 0.000 claims description 77
- 239000002245 particle Substances 0.000 claims description 60
- 239000000178 monomer Substances 0.000 claims description 31
- 108090000790 Enzymes Proteins 0.000 claims description 24
- 102000004190 Enzymes Human genes 0.000 claims description 24
- 239000003995 emulsifying agent Substances 0.000 claims description 17
- 239000013543 active substance Substances 0.000 claims description 15
- 238000007720 emulsion polymerization reaction Methods 0.000 claims description 15
- 150000002118 epoxides Chemical class 0.000 claims description 15
- 229940039227 diagnostic agent Drugs 0.000 claims description 14
- 239000000032 diagnostic agent Substances 0.000 claims description 14
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 239000003999 initiator Substances 0.000 claims description 9
- 229920001577 copolymer Polymers 0.000 claims description 8
- 239000003381 stabilizer Substances 0.000 claims description 7
- 239000000427 antigen Substances 0.000 claims description 5
- 102000036639 antigens Human genes 0.000 claims description 5
- 108091007433 antigens Proteins 0.000 claims description 5
- 229920001519 homopolymer Polymers 0.000 claims description 5
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 claims description 4
- 102000011923 Thyrotropin Human genes 0.000 claims description 4
- 108010061174 Thyrotropin Proteins 0.000 claims description 4
- 239000005556 hormone Substances 0.000 claims description 4
- 229940088597 hormone Drugs 0.000 claims description 4
- 229940034208 thyroxine Drugs 0.000 claims description 4
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000007767 bonding agent Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 description 27
- 229940088598 enzyme Drugs 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 239000000243 solution Substances 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 16
- 239000000203 mixture Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000005119 centrifugation Methods 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 9
- 239000000693 micelle Substances 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 8
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 7
- 230000002209 hydrophobic effect Effects 0.000 description 7
- 238000003018 immunoassay Methods 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 239000000969 carrier Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 108010015776 Glucose oxidase Proteins 0.000 description 5
- 239000004366 Glucose oxidase Substances 0.000 description 5
- 229940116332 glucose oxidase Drugs 0.000 description 5
- 235000019420 glucose oxidase Nutrition 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- 102000003992 Peroxidases Human genes 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 4
- 108040007629 peroxidase activity proteins Proteins 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000001256 steam distillation Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 3
- 125000003172 aldehyde group Chemical group 0.000 description 3
- -1 aminoalkyl acrylates Chemical class 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 108010005774 beta-Galactosidase Proteins 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 238000001212 derivatisation Methods 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 238000005915 ammonolysis reaction Methods 0.000 description 2
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 108010074605 gamma-Globulins Proteins 0.000 description 2
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 208000003532 hypothyroidism Diseases 0.000 description 2
- 230000002989 hypothyroidism Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 229920002454 poly(glycidyl methacrylate) polymer Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000012798 spherical particle Substances 0.000 description 2
- 229920003048 styrene butadiene rubber Polymers 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- SEPPVOUBHWNCAW-FNORWQNLSA-N (E)-4-oxonon-2-enal Chemical compound CCCCCC(=O)\C=C\C=O SEPPVOUBHWNCAW-FNORWQNLSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- JJRUAPNVLBABCN-UHFFFAOYSA-N 2-(ethenoxymethyl)oxirane Chemical compound C=COCC1CO1 JJRUAPNVLBABCN-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- LFDKSGOXWIDWPO-UHFFFAOYSA-N 2-o-ethenyl 1-o-(oxiran-2-ylmethyl) benzene-1,2-dicarboxylate Chemical compound C=COC(=O)C1=CC=CC=C1C(=O)OCC1OC1 LFDKSGOXWIDWPO-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical class C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- WDLUEZJSSHTKAP-UHFFFAOYSA-N acetaldehyde;1,1-diethoxyethane Chemical compound CC=O.CCOC(C)OCC WDLUEZJSSHTKAP-UHFFFAOYSA-N 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000007098 aminolysis reaction Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- HXZFKNYYWGUQMA-UHFFFAOYSA-N butanedioic acid 3-hydroxypyrrolidine-2,5-dione Chemical compound C(CCC(=O)O)(=O)O.OC1C(=O)NC(C1)=O HXZFKNYYWGUQMA-UHFFFAOYSA-N 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 125000004386 diacrylate group Chemical group 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- 239000004815 dispersion polymer Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000036046 immunoreaction Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- 125000005385 peroxodisulfate group Chemical group 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000003488 releasing hormone Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N βâMercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/12—Polymerisation in non-solvents
- C08F2/16—Aqueous medium
- C08F2/22—Emulsion polymerisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C12N11/087—Acrylic polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymerisation Methods In General (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯èŠªæ°Žæ§ã©ããã¯ã¹ç²åãå«ã蚺æè¬ã«
é¢ããã ç¹ã«è¿ éãã€ç°¡åã«å®æœãããã€ãã°ãã°è£žçŒ
ã§èŠ³å¯ããããšãã§ããããã«å ç«åŠã§å€ãã®èšº
æ枬å®ã®ç¯å²å ã§å©çšãããæåæäœè€åç©ã®å
éåå¿ã«ã¯å ç«åŠçã«æŽ»æ§ãªç©è³ªãäŸãã°æäœã®
ãã€ãªã€ãšããŠçæ°Žæ§ã©ããã¯ã¹ç²åãé·ãé䜿
çšãããŠããããã®çæ°Žæ§ã©ããã¯ã¹ç²åã¯å€§ãŠ
ãã¯ããªã¹ãã¬ã³ãã¢ããªããŒãŸãã¯ã³ããªã
ãŒãäŸãã°ã¹ãã¬ã³ïŒãã¿ãžãšã³ã³ããªããŒãŸã
ã¯ã¢ã¯ãªã«ãããªã«ïŒãã¿ãžãšã³ïŒã¹ãã¬ã³ã³ã
ãªããŒïŒABSïŒããæãããã€ãšãã«ãžãšã³é
åã«ãã補é ãããã é·ãéç¥ãããŠãããšãã«ãžãšã³éåã§ã¯ãäž
è¬ã«ïŒæåãæ·»å ãããïŒæ°Žã«é£æº¶æ§ã®ã¢ãããŒ
ãŸãã¯æ°çš®ã®æ°Žã«é£æº¶æ§ã®ã¢ãããŒã®æ··åç©ã
æ°Žãä¹³åå€ããã³æ°Žæº¶æ§éå§å€ãã¢ãããŒã¯ä¹³å
å€ã«ãã€ãŠå°æ»Žã®åœ¢ç¶ã«æ¶²åããããã®éå€æ°ã®
ä¹³åå€ååã®äŒåã«ãã€ãŠäžã§ãäžéšã¯ç©ºã®ãã
ã€äžéšã¯ã¢ãããŒååã«ãã€ãŠæºãããã倧ããª
ãã»ã«ã圢æããããåŸè ã¯ã¢ãããŒã®âå¯æº¶
æ§âãšããŠç€ºãããã氎溶æ§éå§å€ã¯ãæ°Žçžã®å
ã¢ãããŒååã®éåããŸãã¢ãããŒã§æºãããã
ãã»ã«ã§äžŠã³ã«ã¢ãããŒæ»Žã§éåãéå§ãããã¯
掻æ§åããããšã®ã§ããã©ãžã«ã«ã圢æãããã
ããå®éã«ã¯éåã¯èšæœ€ãããã»ã«ã§èµ·ãããã
ãšããã®ãäžæ¹ã§ãã»ã«äžã®ã¢ãããŒæ¿åºŠãåšå²
ã«ãããåã ã®æº¶ããã¢ãããŒååã®æ¿åºŠããã
èãã倧ããããŸãä»æ¹ã§ãã»ã«ã®æŽ»æ§åã®ç¢ºç
ãã¢ãããŒæ»Žã®æ°ã«æ¯ã¹ãŠãã»ã«ã®æ°ãå€ããã
ã«ããããŠé«ãããã§ãããå å¡«ãã»ã«ã®çŽåŸã¯
éåäžã«ãã»ã«ãæçµçã«çç¶ã®ã©ããã¯ã¹ç²å
ã«ç§»è¡ãããŸã§å¢å€§ããã掻æ§åãããªããã»ã«
ã®ä¹³åå€ååããã³æ¶è²»ãããã¢ãããŒæ»Žã®è¡šé¢
ããã®ä¹³åå€ååã¯ã©ããã¯ã¹ç²åã®è¡šé¢ããã
ãããã€çæããããªããŒåæ£æ¶²ã®å®å®åã«åœ¹ç«
ã€ã äŸãã°çé¢æŽ»æ§å€ãŸãã¯æ¹¿æœ€å€ã§ãã€ãŠããä¹³
åå€ãŸãã¯ãšãã«ãžãšã³å®å®å€ã®æ·»å äžã«å ¬ç¥æ¹
æ³ã«ãã補é ãããã©ããã¯ã¹ã¯æ¬¡ã®æ¬ ç¹ãæã€
ãŠããããããã®æ¬ ç¹ã¯ç¹ã«å ç«åŠçã«æŽ»æ§ãªç©
質ã®ãã€ãªã€ãšããŠã®äœ¿çšããã³é£ç¶çãªæº¶æ¶²æž¬
å®ç³»ã§ã®äœ¿çšã劚ããïŒ ïŒ ã©ããã¯ã¹ç²åã®çæ°Žæ§è¡šé¢ã«ææã®å ç«åŠ
çã«æŽ»æ§ãªç©è³ªãäŸãã°æäœã®ä»ã«éç¹ç°çã«
å€æ°ã®ä»ã®è¡æž æåãçµåããïŒ ïŒ å ±æçµåã«ãããåžççã«ã®ã¿çµåããå ç«
åŠçã«æŽ»æ§ãªç©è³ªã¯èšºæè©Šéšã®çµéã®äžã§æž¬å®
äžã«åã³åé¢ããå ŽåãããïŒ ïŒ ãšãã«ãžãšã³éåã§ä¹³åå€ãŸãã¯å®å®å€ãšã
ãŠäœ¿çšãããçé¢æŽ»æ§å€ã氎溶液äžã«æ¡æ£ããŠ
çç©åŠçã«æŽ»æ§ãªããçœè³ªã®æ§é ãããããã€
ãŠæŽ»æ§ãç Žå£ããå ŽåãããïŒ ïŒ å®å®åäœçšãæããçé¢æŽ»æ§å€ãé€ãéã«ã©
ããã¯ã¹æžæ¿æ¶²ãåéãããã€é å¿åé¢ã®éã«
ãå®å®æ§ãããããããã®éçæããæ²æŸ±ç©ã¯
åæžæ¿ãããŠåã®ç¶æ ã«ããã®ãããããŠå°é£
ããŸãã¯ãã¯ãå¯èœã§ã¯ãªãã ãããã®æ¬ ç¹ãåé¿ããããã«æ¢ã«çš®ã ã®ææ¡
ããªããããããããã¯åžžã«åèšã®åé¡ã®äžéšã®
ã¿ã解決ãåŸãã«ããªãã€ãã ã«ã«ããã·ã«åABSâã³ããªããŒããã³ã«ã«
ããã·ã«åã¹ãã¬ã³ïŒãã¿ãžãšã³ã³ããªããŒãã
æããç²åºŠ0.01ã0.9ÎŒïœã®çæ°Žæ§ã©ããã¯ã¹ç²å
ã西ãã€ãåœç¹èš±å ¬å第2203377å·å ¬å ±ããå ¬ç¥
ã§ããããããã¯è¡æž åŠçã«äžæŽ»æ§ã®ãã€ãªã€ãš
ããŠçç©åŠçã«æŽ»æ§ãªããçœè³ªã«å¯ŸããŠäœ¿çšã
ãããã®éããçœè³ªã¯ãã€ãªã€ã«ãã©ããã¯ã¹äž
ã«å°å ¥ãããã«ã«ããã·ã«åºãä»ããŠã¢ããçµå
ã®åœ¢æäžã«å ±æçµåãããã 西ãã€ãåœç¹èš±å ¬é第2812845å·å ¬å ±ããABS
âã³ããªããŒããæããç²åºŠ0.05ã1ÎŒïœã®çæ°Žæ§
ã©ããã¯ã¹ãå ¬ç¥ã§ããããã®å Žåã«ãã©ããã¯
ã¹ã¯ã«ã«ããã·ã«åºã§å€æ§ããããã€åå¿æ§åŽé
ãšçž®åããŠããããã®ããã«å ç«åŠçã«æŽ»æ§ãªç©
質ãå ±æçµåã§ããã ãã®å ¬ç¥ã®çæ°Žæ§ã©ããã¯ã¹ã«ãã€ãŠåèšã®ç¬¬
ïŒã®åé¡ã¯è§£æ±ºããããä»ã®ãã¹ãŠã®æ¬ ç¹ã¯çžå€
ãããååšããã ãããã€ãŠçæ°Žæ§ã©ããã¯ã¹ã®ä»£ããã«èŠªæ°Žæ§
ã²ã«ãå ç«åŠçã«æŽ»æ§ãªç©è³ªã®ãã€ãªã€ãšããŠäœ¿
çšããããšãè©Šã¿ãããã芪氎æ§ã²ã«ã¯åžçæ§ã
å šããŸãã¯ããããŠå ãããæãããä»æ¹ããçœ
質ã®ãããã²ã«ãžã®å ±æçµåã¯å ¬ç¥ã§ããã®ã§ã
ãã®è£œæ³ããã³ç²åºŠã«åºã¥ããŠâã©ããã¯ã¹âãš
瀺ããŠãããâãã€ã¯ãã²ã«âãææ¡ããããã
ãã芪氎æ§ã©ããã¯ã¹ã¯äŸãã°ç±³åœç¹èš±ç¬¬
4138383å·æ现æžããå ¬ç¥ã§ããã該ã©ããã¯ã¹
ã¯0.35ÎŒïœãããå°ããªçŽåŸãæããç圢ç²åã
ãæããã©ãžã«ã«ã«ãã€ãŠéå§ãããæ°Žæ§ãšãã«
ãžãšã³éåã®æ¡ä»¶äžã«è£œé ããããã®éã¢ãããŒ
ãšããŠã¢ã¯ãªã«ã¢ãããã¢ã¯ãªã«é žãã¡ã¿ã¯ãªã«
é žãŸãã¯ã¢ã¯ãªã¬ãŒãã䜿çšããããä¹³åå€ãšã
ãŠã¯äŸãã°éå±ç³ããã䜿çšããããããããŠåŸ
ããã芪氎æ§ãã€ã¯ãã²ã«ã«çç©åŠçããã³ïŒãŸ
ãã¯å ç«åŠçã«æŽ»æ§ãªç©è³ªãèªäœå ¬ç¥ã®æ¹æ³ã§ã«
ã«ããžã€ããâããªããžãŸãã¯ã°ã«ã¿ã«ãžã¢ã«ã
ããâããªããžãä»ããŠå ±æçµåãããããã«ã
ã€ãŠåèšã®ç¬¬ïŒãšç¬¬ïŒã®åé¡ã解決ããããã第
ïŒãšç¬¬ïŒã®åé¡ã¯è§£æ±ºãããªãããããšããã®ã
ãšãã«ãžãšã³éåã¯çžå€ããä¹³åå€ãŸãã¯å®å®å€
ã®æ·»å äžã«å®æœããªããã°ãªããªãããã§ããã æ¬çºæã®èª²é¡ã¯ãåèšã®ïŒã€ã®æ¬ ç¹ãã¹ãŠãå
é¿ããããšã®ã§ãã芪氎æ§ã©ããã¯ã¹ãå«æãã
蚺æè¬ãèŠãåºãããšã§ããããããã€ãŠæ¬çºæ
ã®èª²é¡ã¯ãç¹ã«çç©åŠçããã³ïŒãŸãã¯å ç«åŠç
ã«æŽ»æ§ãªç©è³ªãå ±æçµåããããšãã§ããçç©åŠ
çã«æŽ»æ§ãªããçœè³ªã®æ§é ããããã€ãŠæŽ»æ§ãæ
ãªããããã®å®å®æ§ãé å¿åé¢ã®éã«ããããã
ãã€åéãããã€åŒç¶ãåã³å®¹æã«æžæ¿ãããã
ãšã®ã§ãã芪氎æ§ã©ããã¯ã¹ç²åãå«æãã蚺æ
è¬ãèŠåºãããšã§ããã ãã®èª²é¡ã¯æ¬çºæã«ããã°æ°Žã«é£æº¶æ§ã®ã¢ãã
ãŒã®ãã¢ããªããŒãŸãã¯ã³ããªããŒããæã芪氎
æ§ã©ããã¯ã¹ç²åãå«æãã蚺æè¬ã«ãã€ãŠè§£æ±º
ãããã該芪氎æ§ã©ããã¯ã¹ç²åã¯æ°Žæº¶æ§ã®ãã©
ãžã«ã«ã圢æããéå§å€ã®ååšã§ããããä¹³å
å€ãå®å®å€ãŸãã¯æ¹¿æœ€å€ãæ·»å ããã«ãšãã«ãžãš
ã³éåã«ãã€ãŠè£œé å¯èœã§ããããã€ãã¢ããªã
ãŒã®å Žåã«ã¢ãããŒãããããã¯ã³ããªããŒã®å Ž
åã«ã¢ãããŒé¡ã®äžéšãååäžã«å°ãªããšãïŒå
ã®éåå¯èœãªïŒ£ïŒïŒ£âäºéçµåãæãããšããã·
ãã§ããã ææ³å€ã«ãåé ã§åŒçšãããå ¬ç¥æè¡ã«ãèšè¿°
ãããŠãããåœæ¥çã§é·ãéæ¯é çã§ãã€ãææ³
ã«åããŠä¹³åå€ãå®å®å€ãŸãã¯æ¹¿æœ€å€ã®æ·»å ããš
ãã«ãžãšã³éåã®å®æœã«ãŸã€ããå¿ èŠã§ã¯ãªãã
ãšã瀺ãããããããã€ãŠãä¹³åå€ãšããŠäœ¿çšã
ããéå±ç³ãããŸãã¯çé¢æŽ»æ§å€ã¯ã©ããã¯ã¹ç²
åããæ¡æ£ãããã€ã©ããã¯ã¹ç²åã«å ±æçµåã
ãããçœè³ªã®çç©åŠç掻æ§ãæãªããŸãã¯å®å šã«
ç Žå£ããããã«åŸæ¥ã¯ç¡æ¡ä»¶ã«å¿ èŠã§ãã€ããã
ãªããŒã®ã©ããã¯ã¹ç²åããã®å€§ãŠãã¯ããããŠ
å°é£ãã€ç ©éãªä¹³åå€ã®é€å»ãçç¥ãããã å°ãªããšãïŒåã®éåå¯èœãªäºéçµåãå«ãã°
ãªã·ãžã«ååç©ãã¢ãããŒãšããŠäœ¿çšããã®ãã
ãããŠæå©ã§ãããšç€ºãããã該ååç©ã®æ§é ã¯
éåæ§ã®äºéçµåäžã«çæ°Žæ§éšåããã³ãšããã·
ãåºããªãã·ã©ã³ç°äžã«åæã«èŠªæ°Žæ§éšåãæã
ããçæããã©ããã¯ã¹æžæ¿æ¶²ã¯ä¹³åå€ãå®å®å€
ãŸãã¯æ¹¿æœ€å€ã®äžåšã«ããããããåéããªãã
ã©ããã¯ã¹æžæ¿æ¶²ã®å®å®åã¯é å¿åé¢ã®éã«ãã
ããããªããæ«ç«¯ãšããã·ãåºã¯çš®ã ã®åå¿ïŒå
æ°Žå解ãã¢ã³ã¢ããªã·ã¹ãã¢ãããªã·ã¹ãçž®åïŒ
ãããããŠåãæãã®ã§ãšããã·ãåºã¯ååæ£ç³»
ã«åæ£ããã©ããã¯ã¹çäœã®è¡šé¢ã該ãšããã·ã
åºãæ°Žçžæ¹åã«é åãããããã«ããã€ãŠããã«
ã¡ãããªãã ã¢ãããŒãšããŠã¯æå©ã«ã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬
ãŒããã°ãªã·ãžã«ã¢ã¯ãªã¬ãŒããã°ãªã·ãžã«ãã
ã«ãšãŒãã«ãã°ãªã·ãžã«ããã«ãã¿ã¬ãŒãããã³
ïŒïŒïŒâãšããã·ãã(1)ãšã³ã䜿çšãããããã®
éãããã®ã¢ãããŒã®ïŒçš®ãå°ã䜿çšãããã®çµ
æãçæãã芪氎æ§ã©ããã¯ã¹ç²åã¯ãã¢ããªã
ãŒã§ãããããããã®ã¢ãããŒã®æ··åç©ãå ±éå
ããŠãããã ãšããã·ãåºã®å«éãå¶åŸ¡ããããã«åèšã®ã°
ãªã·ãžã«ååç©ïŒçš®ãŸãã¯æ°çš®ãšäžç·ã«ä»ã®ã¢ã
ããŒãäŸãã°ã¹ãã¬ã³ããžãšã³ãã¢ã¯ãªã«ã¢ã
ããã¡ã¿ã¯ãªã«ã¢ãããã¢ã«ãã«âãããããã·
ã¢ã«ãã«âããã³ã¢ããã¢ã«ãã«ã¢ã¯ãªã¬ãŒãã
ã¢ã«ãã«âãããããã·ã¢ã«ãã«âããã³ã¢ãã
ã¢ã«ãã«ã¡ã¿ã¯ãªã¬ãŒããããã«ãšãŒãã«ããã
ã«ãšã¹ãã«ãâããã«ãããªãã³çãå ±éåã
ãããšãã§ããã çè²æãŸãã¯è¢å æ§ååç©ãäŸãã°ãã«ãªã¬ã»
ã€ã³ã®ã¢ãããŒã®éåæ§èªå°äœã®ååšã§éåããŠ
ãããããã®ããã«ããŠãããŸãã¯åç©ã®çµç¹ã§
æåãããã¯æäœãæ€åºããããã«å¥œé©ã§ããç
è²ããããããã¯è¢å æ§ã®ã©ããã¯ã¹ç²åãåŸã
ããããã®æ€åºæ¹æ³ã¯çµç¹åŠã§çµç¹æçã補é ã
ãã®ã«ç¹ã«å¥œé©ã§ãããã¢ãããŒã®éåæ§èªå°äœ
ãšããŠã¯æå©ã«çè²æãããã¯è¢å æ§ååç©ã䜿
çšããããã®äžã«èªäœå ¬ç¥ã®æ¹æ³ã§ã¡ã¿ã¯ãªã«åº
ãããã¯ã¢ã¯ãªã«åºãå°å ¥ãããã çæããã©ããã¯ã¹ç²åã®æ°Žã«å¯Ÿããé£æº¶æ§ã
é«ããããã«ãšãã«ãžãšã³éåäžã«åžžçšã®æ¶æ©
å€ãäŸãã°ã¢ã«ãã¬ã³âãŸãã¯ããããã·ã¢ã«ã
ã¬ã³ãžã¢ã¯ãªã¬ãŒããã¢ã«ãã¬ã³âãŸãã¯ããã
ãã·ã¢ã«ãã¬ã³ãžã¡ã¿ã¯ãªã¬ãŒããã¢ã«ãã¬ã³ã
ã¹ã¢ã¯ãªã«ã¢ãããŸãã¯ã¢ã«ãã¬ã³ãã¹ã¢ã¯ãªã«
ã¡ã¿ã¯ãªã«ã¢ããããžããã«ãã³ãŒã³çãæ·»å ã
ãŠãããã éå§å€ãšããŠãšãã«ãžãšã³éåã§åžžçšã®æ°Žæº¶æ§
éå§å€ã䜿çšããããšãã§ãããæå©ã«ãã«ãªã
ãœãžã¹ã«ããšãŒãããã«ãªããœãã¬ãŒããéé žå
æ°ŽçŽ ãŸãã¯å¥œé©ãªã¬ããã¯ã¹ç³»ã䜿çšãããã æ°Žã«é£æº¶æ§ã®ã¢ãããŒïŒçš®ãŸãã¯æ°çš®ãä¹³åå€
äžå«ã®ãšãã«ãžãšã³éåã«ãã芪氎æ§ã©ããã¯ã¹
ç²åã補é ããããã®æ¹æ³ã¯ç©ºäžé žçŽ ãããã¯é
é¢ã®é žçŽ ã«å¯ŸããŠææã§ããããããã€ãŠé žçŽ ã
ãã¹ãŠã®ããªããŒæåããã³å®¹åšããååãªç ®
沞ãäžæº¶æ§ã¬ã¹é°å²æ°äžã«ãããèžæºãŸãã¯çª
çŽ ãã¢ã«ãŽã³ãŸãã¯ä»ã®äžæŽ»æ§ã¬ã¹ã®å°éã«ãã
ããããŠæ éã«é€å»ããªããã°ãªããªãã ä¹³åå€äžå«ã®ãšãã«ãžãšã³éåã¯æå©ã«æ°Žçžå¯Ÿ
ã¢ãããŒçžã®æµŽæ¯ã容éã«é¢ããŠïŒïŒïŒã16ïŒïŒ
ã§å®æœããã æ°Žçžã«æº¶ããéå§å€ã®æ¿åºŠã¯æå©ã«0.5ã1.5
ïœïŒã§ããããã€ã¢ãããŒçžäžã®ãšããã·ãã®
æ¿åºŠã¯æå©ã«ïŒã100ééïŒ ã§ããã ãšãã«ãžãšã³éåã¯æå©ã«æž©åºŠïŒã80âã§å®æœ
ããã枩床ã¯éžæãããéå§å€ã«äŸåããããã«
ãªããœäºç¡«é žã«ãªãŠã ã®äœ¿çšã®éã«ã¯æå©ã«60ã
70âã§äœæ¥ãããåæ§ã«åå¿æéã¯éå§å€ã®éžæ
ã«äŸåããïŒã40æéã§ããã 芪氎æ§ã©ããã¯ã¹ç²åã¯å³å¯ã«ç圢ã§ãååæ£
ç³»ã§åæ£ããããã€çŽåŸ0.15ã1.5ÎŒïœã®äºãã«ã»
ãŒåã倧ããã®ç²åã§ããã 芪氎æ§ã©ããã¯ã¹ç²åã¯ãšãã«ãžãšã³éåçµäº
åŸå°éåãããªãã¢ãããŒã®æ®åãå«ãã§ããå Ž
åãããããã®æ®åã¯æ°Žèžæ°èžæºãŸãã¯éæã«ã
ãé€å»ããããšãã§ããããã®å Žåã«ãé å¿åé¢
ã«ããã©ããã¯ã¹ç²åãå®å®æ§ãããããã«æ²é
ãããããšãã§ãããã®çµæåŒç¶ãååæ£ããã
ãšãã§ããã芪氎æ§ã©ããã¯ã¹ç²åã®ç¹ã«æå©ãª
æ§è³ªã¯ä¿æãããããã®ããã«ããŠæ¬çºæã«ãã
ã©ããã¯ã¹ã¯æ°åºŠã®é å¿åé¢ããã³ãã«ã³ããŒã·
ãšã³ã«ãã€ãŠç°¡åã«ç²Ÿè£œããããšãã§ããã ã©ããã¯ã¹ã®æ«ç«¯ã®éé¢ãšããã·ãåºã¯çš®ã ã®
ååŠç©è³ªã«å¯ŸããŠé«åå¿æ§ã§ããããããã€ãŠå®¹
æã«å æ°Žå解ã§ããéãšãŠçŽ é žå¡©ãããã¯éãšãŠ
çŽ é žãçšããŠé žåããŠã¢ã«ãããåºã«ããã¢ã³ã¢
ãã¢ã第ïŒã¢ãã³ããžã¢ãã³ãŸãã¯ããã©ãžã³ãš
åå¿ãããŠç¬¬ïŒãŸãã¯ç¬¬ïŒã¢ããåºã«ãããŸãã¯
ä»ã®å ¬ç¥ã®åå¿ãçšããŠå€æ§ããããšãã§ããã
ã©ããã¯ã¹ã®ãšãã«ãžãšã³ã¯ä¹³åå€ãæ¬ ããŠãã
ã«ãããããããšããã·ãåºã®å€æ§ãææã«ãã
ãšãã«ãžãšã³éåã®éãå®æœãåŸãã»ã©é«ãå®å®
æ§ãæãããã®ããã«æ¢ã«éååå¿ããè¡šé¢ãäŸ
ãã°ç¬¬ïŒã¢ããåºã§å€æ§ãããã©ããã¯ã¹ãçæ
ããã次ãã§å€æ§ãããããŸãã¯èªå°äœåããã
ãšããã·ãåºã¯ããã€ãªã€ãšããŠäœçšãã芪氎æ§
ã©ããã¯ã¹ç²åã«å ±æçµåãããçç©åŠçã«ãã
ã³ïŒãŸãã¯å ç«åŠçã«æŽ»æ§ãªããçœè³ªãšã®âçµå
ïŒKupplungïŒâã«äœ¿çšãããã åèšã®èª²é¡ã¯èŠªæ°Žæ§ã©ããã¯ã¹ç²åãçç©åŠç
ããã³ïŒãŸãã¯å ç«åŠçã«æŽ»æ§ãªç©è³ªã®è¡æž åŠç
ã«äžæŽ»æ§ãªãã€ãªã€ãšããŠãäŸãã°ãããããã
ãçœè³ªãé µçŽ ããã«ã¢ã³ããã¿ãã³ãæåãæäœ
ããã³åŸ®çç©ã®ãã€ãªã€ãšããŠäœ¿çšããããšã«ã
ã解決ãããã æ¬çºæã®ç®çã¯ãã€ãªã€ãšããŠèŠªæ°Žæ§ã©ããã¯
ã¹ç²åããã³ãã®ãã€ãªã€ã«çŽæ¥ãŸãã¯âããªã
ãžâãšããŠã®çµåå€ãä»ããŠå ±æçµåãããçç©
åŠçããã³ïŒãŸãã¯å ç«åŠçã«æŽ»æ§ãªåèšã®ç©è³ª
ãå«ã蚺æè¬ã§ããã æ¬çºæã«ãã蚺æè¬ã¯åäœå çŽ æšèå ç«å®éæ³
ïŒRIAïŒãé µçŽ å ç«å®éæ³ïŒEIAïŒããã³ãããã
ELISAïŒé µçŽ çµåå ç«åžçå®éæ³ïŒã§äœ¿çšããã®
ã«ç¹ã«å¥œé©ã§ããã äŸ ïŒïŒåèïŒ ãã«ãªããœäºç¡«é žã«ãªãŠã ïŒK2S2O8ïŒ0.08ïœ
ãèžæºæ°Ž80mlã«æº¶ããããã€ïŒåéçªçŽ ãå°éã
ããããšã«ãã空äžé žçŽ ãæé€ãããåæã«ã°ãª
ã·ãžã«ã¡ã¿ã¯ãªã¬ãŒã10mlããåæ§ã«ç©ºäžé žçŽ ã
é€ããïŒæåãã¬ã©ã¹åå¿åšã«å ¥ãããã€æŽã«10
åéçªçŽ ã§åŠçããã次ãã§åå¿åšãéãããã€
åå¿ã枩床65âã§äžæã«æ¹æäžã«ïŒæéå®æœã
ãããã®æéã®åŸå€æçã¯98ïŒ ã§ãããåå¿çæ
ç©ã¯çŽåŸ0.44ÎŒïœã®ç圢ã®ãååæ£ç³»ã«åé ãã
ãããªã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬ãŒãç²åããæãã©
ããã¯ã¹ã§ããã äŸ ïŒïŒåèïŒ äŸïŒãšåæ§ã«ããŠK2S2O80.08ïœã溶ãããèž
æºæ°Ž160mlããã³ã°ãªã·ãžã«ã¡ã¿ã¯ã¬ãŒã15éé
ïŒ ãšã¹ãã¬ã³85ééïŒ ã®æ··åç©10mlãå¥åã«é žçŽ
ãæé€ãããã€æž©åºŠ65âã§äžæã«æ¹æäžã«ïŒæé
äºãã«åå¿ããããå€æçã¯71.6ïŒ ã§ãããéå
ããªãæ®éã¢ãããŒãæ°Žèžæ°èžæºã«ããé€ããç
ããååæ£ç³»ã³ããªããŒã®ã©ããã¯ã¹ç²åã¯çŽåŸ
0.22ÎŒïœãæããã äŸ ïŒïŒåèïŒ äŸïŒãšåæ§ã«ããŠãèžæºæ°Ž100mläžã®
K2S2O80.1ïœã®æº¶æ¶²ããã³ã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬
ãŒã15ééïŒ ãšé ¢é žããã«85ééïŒ ã®æ··åç©10ml
ãäºãã«åå¿ããããå€æçã¯80ïŒ ã§ãããæ®é
ã¢ãããŒãæ°Žèžæ°èžæºã«ããé€ããçæããã©ã
ãã¯ã¹ã¯çŽåŸ0.16ÎŒïœã®ååæ£ç³»ãç圢ç²åã§ã
ãã ããããŠè£œé ãããã©ããã¯ã¹100mlã0.1Mâ
NaOH溶液100mlãšæ··åãããã€æž©åºŠçŽ25âã§24
æéæŸçœ®ãããå æ°Žå解äžããã³åŸãã©ããã¯ã¹
ã®å®å®æ§ã¯ä¿æãããããšãã«ãžãšã³ãé å¿åé¢
ããäžæŸã¿ããã«ã³ããŒã·ãšã³ãããã€åºäœçžã
åã³æ°Žäžã«åæ£ããããé å¿åé¢ããã³ååæ£ã
ïŒåºŠç¹°è¿ããçããäžæ§ãšãã«ãžãšã³ãïŒïŒâ
H2SO4ã§PHïŒã«ãããã€éãšãŠçŽ é žããšããã·
ãåºãšåœéã§å ãããé žåã¯25âã§çŽ24æéè¡ãª
ããåŒç¶ãæªåå¿äœååç©è³ªãéæã«ãã€ãŠé€
ããå®å®ãªãšãã«ãžãšã³ã®å€æ§ã©ããã¯ã¹ç²åã¯
ã¢ã«ãããåº2.8ééïŒ ãŸãã¯0.97ããªã¢ã«ïŒïœ
ãå«æããã äŸ ïŒïŒåèïŒ äŸïŒã®ããã«ããŠèžæºæ°Ž100mläžã®K2S2O80.1
ïœã®æº¶æ¶²ããã³ã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬ãŒã15éé
ïŒ ãšã€ãœãã¬ã³85ééïŒ ã®æ··åç©10mlã枩床65â
ã§24æéåå¿ããããå€æçã¯76ïŒ ã§ãããåŒç¶
ãæ®éã¢ãããŒãæ°Žèžæ°èžæºã«ããé€ãããã®é
çŽåŸ0.25ÎŒïœã®å®å®ãªãååæ£ç³»ã«åæ£ããç圢
ã®ã©ããã¯ã¹ç²åãçããã åŒç¶ããã®ãšãã«ãžãšã³100mlã«ã¢ã³ã¢ãã¢æ°Ž
溶液ïŒ25ïŒ ïŒ100mlãå ãããã€å®€æž©ã§24æéæŸ
眮ãããã®éãšããã·ãåºãã¢ã³ã¢ããªã·ã¹ã«ã
ã€ãŠã¢ããåºã«å€ãããåŒç¶ãåå¿çæç©ãéãš
ãŠçŽ é žã§åŠçãããã®éã¢ã«ãããåº4.5ééïŒ
ãŸãã¯1.55ããªã¢ã«ïŒïœãå«æããã©ããã¯ã¹ã
çããã äŸ ïŒïŒåèïŒ äŸïŒã®ããã«ããŠæ°Ž1.5äžã®K2S2O81.5ïœã®æº¶
液ããã³ã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬ãŒã15mlãå¥åã«
é žçŽ ãé€ãããã€äºãã«åå¿ããããæŽã«é žçŽ äž
å«ã®ã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬ãŒã120mlãé žçŽ æé€
äžã«ïŒæéã®éåå¿å®¹åšã«é£ç¶çã«æ»Žäžããã次
ãã§æŽã«30åééåãç¶ãããå€æçã¯85ïŒ ã§ã
ãããã€çæããç²åã¯çŽåŸ1.1ÎŒïœãæããã äŸ ïŒïŒåèïŒ äŸïŒã®ããã«ããŠã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬ãŒãïŒ
ééïŒ ãšã¹ãã¬ã³99ééïŒ ã®æ··åç©10mlããã³èž
æºæ°Ž100mläžã®K2S2O80.1ïœã®æº¶æ¶²ã65âã§22æ
ééåãããã®éçŽåŸ0.5ÎŒïœã®èŠªæ°Žæ§ã©ããã¯ã¹
ç²åãçæãããå€æçã¯90ïŒ ã§ããã äŸ ïŒïŒåèïŒ äŸïŒã«ãã補é ãããã©ããã¯ã¹æžæ¿æ¶²20mlã
2Nâèæ§ãœãŒã液ïŒmlãšãšãã«äžå€ã«ããã€ãŠ
宀枩ã§æ¹æãã次ãã§ïŒæéæ°Žã«å¯ŸããŠéæã
ããæ®æºããæžæ¿æ¶²ãéãšãŠçŽ é žãããªãŠã 100
mgã®æ·»å ã«ããPHïŒã«èª¿ç¯ãããã€äžå€ã«ããã€
ãŠå®€æž©ã§æ¹æãã次ãã§ïŒæéèžæºæ°Žã«å¯ŸããŠé
æããã äŸ ïŒïŒåèïŒ äŸïŒã«ãã補é ãããã©ããã¯ã¹æžæ¿æ¶²20mlã
æ¿ã¢ã³ã¢ãã¢æº¶æ¶²10mlãšãšãã«å®€æž©ã§20æéæ¹æ
ãããã€æµæ°Žã«å¯ŸããŠ48æééæãããåŸããã
æžæ¿æ¶²ãé å¿åé¢ããã也ç¥ç©è³ªã®çªçŽ å«éã¯çŽ
ïŒïŒ ã§ãããããã¯åçŽ10ã®ãšããã·ãåäœã®ã¢
ããåã«çžåœãããããè¡šé¢ã®åªããåå¿ã§ã¯ç¢º
å®ã«ããé«ãèªå°äœå床ã«çžåœãããé å¿åé¢ã
ããåºäœç©è³ªã0.1Nâèæ§ãœãŒã液20mlã§åžå
ãããããã«æ¹æäžã«ãžã¡ãã«ãã«ã ã¢ããïŒml
ã«æº¶ãããã³ãã¯é žããããã·ãµã¯ã·ã³ã€ãããš
ã¹ãã«âã¢ããã¢ã»ãã¢ã«ãããâã¢ã»ã¿ãŒã«
1.5ïœã滎äžãããçæããæžæ¿æ¶²ãæŽã«ïŒæé
æ¹æãã次ãã§1Nâå¡©é žã§PHïŒã«ãããã€æµã
ãèžæºæ°Žã«å¯ŸããŠ12æééæããã äŸ ïŒïŒåèïŒ äŸïŒã«ãã補é ãããã©ããã¯ã¹æžæ¿æ¶²20mlã«
Na2Sã»9H2O0.5ïœãå ãããã€å®€æž©ã§ïŒæ¥æ¹æ
ãããåŒç¶ãæžæ¿æ¶²ã®èãããªããªããŸã§æµãã
èžæºæ°Žã«å¯ŸããŠéæãã次ãã§æžæ¿æ¶²ãé å¿åé¢
ããã也ç¥ç©è³ªã¯ã€ãªãŠçŽïŒïŒ ãæããããã¯çŽ
10ã®ãšããã·ãåäœã®èªå°äœåã«çžåœããè¡šé¢ã§
ã®åªããåå¿ã§ã¯ç¢ºå®ã«ããé«ãèªå°äœå床ã«çž
åœããã é å¿åé¢ãããçæç©ã«ãžã¡ãã«ãã«ã ã¢ãã
ïŒmlã«æº¶ãããïŒâãã¬ã€ã³ã€ãããããµã³é žã
ãããã·ãµã¯ã·ã³ã€ãããšã¹ãã«ïŒïœãå ãã宀
æž©ã§ïŒæéæ¹æãã次ãã§æµããèžæºæ°Žã«å¯ŸããŠ
12æééæããã äŸ 10 ã©ããã¯ã¹âγâã°ãããªã³ã³ã³ãžãŠã²ãŒã
ïŒKonjugatïŒã®åœ¢æ γâã°ãããªã³æº¶æ¶²ïŒmlïŒããçœè³ª56.6mgå«
æïŒã« (a) äŸïŒã«ãã補é ãããã©ããã¯ã¹æžæ¿æ¶² (b) äŸïŒã«ããèªå°äœåãããã©ããã¯ã¹æžæ¿æ¶² (c) äŸïŒã«ããèªå°äœåããã ã (d) äŸïŒã«ããèªå°äœåããã ã å20mlãå ãããã€å®€æž©ã§12æééæãããæ®ç
ããæžæ¿æ¶²ãé å¿åé¢ãããåŒç¶ãäžæŸã¿æ¶²äžã®
éé¢ã®ããçœè³ªã枬å®ãããå®æž¬å€ããã©ããã¯
ã¹ç²åã«çµåãããå²åãèšç®ããããšãã§ã
ããããã«ããã° ããã(a)ã¯Î³âã°ãããªã³ ïŒmgãçµåããŠå«æã ã (b)㯠ã 43mgãçµåããŠå«æã ã (c)㯠ã 15mgãçµåããŠå«æã ã (d)㯠ã 19mgãçµåããŠå«æã äŸ 11 ã©ããã¯ã¹âIgGâã³ã³ãžãŠã²ãŒã äŸ10ã®ããã«ããŠIgGâ溶液ããã³çš®ã ã®ã©ã
ãã¯ã¹æžæ¿æ¶²ããã©ããã¯ã¹âIgGã³ã³ãžãŠã²ãŒ
ãã補é ãããæäœè€åäœåœ¢æã«ãã€ãŠã©ããã¯
ã¹ç²åã«IgGâååãç©èŒãããŠããããšãæ€åº
ãããã 以äžæ¬çºæã«ãã芪氎æ§ã©ããã¯ã¹ç²åã®äœ¿çš
äŸãšããŠã詳现ã«ã¯ãããžã®æT4âè¡æž ããã®
T4âæäœãçšããŠãããã·ã³ïŒT4ïŒãå ç«å®é
ããããã®ãããã³äºéæäœâåé¢æ³ãçšããŠè¡
æž äžã®ãããã¬ãªãããã³ïŒTSHïŒãå®éãã
ããã®ïŒã€ã®èšºæè¬ãèšèŒããã äŸ 12 ãããžã®æT4âè¡æž ã«å¯Ÿãããã€ãªã€ãšããŠ
ã®ãã¢ããªã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬ãŒãã©ããã¯
ã¹ç²åã®äœ¿çšïŒT4âELISAãè¡ãªãããã®èšº
æè¬ ãããã·ã³ïŒT4ïŒãELISAãçšããŠå®éãã
ããã«å ããããžã®æT4âè¡æž ããã®T4âæäœ
ãæ¬çºæã«ãã芪氎æ§ãã¢ããªã°ãªã·ãžã«ã¡ã¿ã¯
ãªã¬ãŒãã©ããã¯ã¹ç²åã«ã該ç²åãäŸïŒãïŒã®
ããããã«ãã€ãŠèªå°äœåãããã€äŸ10ããã³11
ãšåæ§ã«ããŠT4âæäœãšåå¿ãããããšã«ãã€
ãŠå ±æçµåããããããããŠåŸããããœãªããâ
ããšãŒã¹ïŒSolidâFaceïŒâæäœã¯è©Šéšã®ããã®
第ïŒè©Šè¬ã§ããã第ïŒè©Šè¬ãšããŠT4ãèªäœå ¬ç¥
ã®æ¹æ³ã§å¥œé©ãªé µçŽ ãäŸãã°ãã«ãªãã·ããŒãŒ
ïŒPODïŒãŸãã¯Î²âã¬ã©ã¯ãã·ããŒãŒïŒÎ²âGalïŒ
ã§æšèãããããªãã¡çµåããŠé µçŽ ã³ã³ãžãŠã²ãŒ
ãã«ãããé µçŽ ãšããŠãã®äŸã§ã¯Î²âGalã䜿çš
ããã第ïŒè©Šè¬ã¯æªç¥éã®T4ãå«æããè©Šæã§
ããããã€ç¬¬ïŒè©Šè¬ã¯é µçŽ ã³ã³ãžãŠã²ãŒãã®Î²â
Galã®åžžçšã®åºè³ªã§ããã詳现ã«ã¯ãã®äŸã§ã¯ã
ãªã¹âHClâç·©è¡æ¶²ïŒPH7.3ïŒäžã®ãããããšã
ã«âβâã¬ã©ã¯ãã·ãã§ããã è©Šéšã®åçã¯æ¬¡ã®ïŒã€ã®åå¿çµéã«åºã¥ãïŒ ïŒ äžæ¹ã®èŠªæ°Žæ§ã©ããã¯ã¹ç²åã«å ±æçµåãã
T4âæäœãšä»æ¹ã®é µçŽ æšèT4ïŒâé µçŽ ã³ã³ãžãŠ
ã²ãŒãâïŒãšè©Šæäžã«å«ãŸããéé¢ã®T4ãšã®é
ã®å ç«åå¿ããã®åå¿ã§ã¯ãœãªããâããšãŒã¹
âæäœãé µçŽ ã³ã³ãžãŠã²ãŒãããã³è©Šæã®T4
ã®éã«ç«¶åççµåãèµ·ããã ïŒ ïŒ¢ïŒïŒŠâåé¢ïŒïŒ¢ïŒçµåãïŒéé¢ïŒããã
ã¯çµåããé µçŽ ã³ã³ãžãŠã²ãŒã(B)ãšçµåããªã
é µçŽ ã³ã³ãžãŠã²ãŒã(F)ã®åé¢ã§ããããã®åé¢
ã¯æå©ã«é å¿åé¢ãŸãã¯äŸãã°æ°ŽãŸãã¯å¥œé©ãª
ç·©è¡æ¶²ã«å¯Ÿããéæã«ãã€ãŠéæãããã ïŒ é µçŽ ã³ã³ãžãŠã²ãŒããšåžžçšã®ã䜿çšãããé µ
çŽ ã«é¢ããŠç¹ç°çãªåºè³ªãšã®éã«é²è¡ãããã€
æ¯è²æ³ãŸãã¯ä»ã®å ¬ç¥æ¹æ³ã§è¿œè·¡ããããšã®ã§
ããé µçŽ æ€åºåå¿ãé µçŽ æŽ»æ§ã¯äžæŸã¿æ¶²ïŒéé¢
éšåïŒäžã§ããŸãã¯åæžæ¿ãããæ²æŸ±ç©ïŒçµå
éšåïŒäžã§æž¬å®ããããšãã§ããã è©Šéšå®æœ åèšã®ããã«ããŠè£œé ãããã©ããã¯ã¹âæ
T4æžæ¿æ¶²ãæ°ŽãŸãã¯ç·©è¡æ¶²äžã§æ¯ïŒïŒ1000ã§åž
éããããã®æžæ¿æ¶²0.5mlã«çš®ã ã®æ¢ç¥éã®T4â
å«éãæããT4âè¡æž æšäžæº¶æ¶²100ÎŒããã³T4
âβâGalâã³ã³ãžãŠã²ãŒã溶液100ÎŒãå ã
ããåå¿æ··åç©ã宀枩ã§30åææž©ä¿æãããææž©
ä¿æã®éïŒããããäžæã«æ¯çªãããã€åãT4
âæšæºå«éãæããïŒããããåã«æŸçœ®ããã次
ãã§ããããæžæ¿æ¶²ãé å¿åé¢ãããã€ïŒŠâçžã
ååšããäžæŸã¿æ¶²ãåé¢ãããâçžãããªãã¡
ãœãªããâããšãŒã¹æäœã«çµåããT4âβâGal
ã³ã³ãžãŠã²ãŒãã¯æ²æŸ±ç©äžã«ååšãããé µçŽ æŽ»æ§
ã枬å®ããããã«ããã ïœâãããããšãã«âβâã¬ã©ã¯ãã·ãïŒã·ã°ã
ç€ŸïŒ 450mgïŒ å¡©åãããªãŠã 100ããªã¢ã« å¡©åãã°ãã·ãŠã 10ããªã¢ã« ããªã¹ç·©è¡å€ïŒHCl 10ããªã¢ã« ã¡ã«ã«ãããšã¿ããŒã« 0.4vïŒïœïŒ ããæããPH7.3ã®éå°ã®åºè³ªæº¶æ¶²ã«å ãããã€
å ¬ç¥æ¹æ³ã§æ³¢é·405nïœã§åžå 床ã枬å®ãããå€
éšã®æ©æ¢°çãªæ··åãããªãå Žåã«æžæ¿ç¶æ ã§ä¿æ
ãããã©ããã¯ã¹ç²åãçŽ11ïŒ æžå°ããã·ã°ãã«
ãäžããããšã瀺ãããã ãã®ããã«ããŠT4âæ€éæ²ç·ã枬å®ããåŸã
åŒç¶ãåæ§ã«ããŠT4âæšæºè¡æž 100ÎŒã®ä»£ãã
ã«æªç¥éã®T4å«éã®è©Šæãããã100ÎŒã䜿çš
ãããã€åæžæ¿åŸã®ïŒ¢âçžã®åžå 床ãåºè³ªæº¶æ¶²äž
ã§æž¬å®ããããšã«ããå®éãè¡ãªã€ãã 芪氎æ§ã©ããã¯ã¹ç²åãæäœããã³æåã®ãã€
ãªã€ãšããŠããããŠå¥œé©ã§ããããã€ãããã®å
ç«åå¿æ§ã®æãªããªãããšãèªãããããããã€
ãŠèŠªæ°Žæ§ã©ããã¯ã¹ç²åã¯ãœãªããâããšãŒã¹â
é µçŽ å ç«è©Šéšã§ãã€ãªã€ãšããŠæå©ã«äœ¿çšããã
ãšãã§ãããæŽã«ç·©è¡å€æ¡ä»¶ã«ãã芪氎æ§ã©ãã
ã¯ã¹ç²åãé·æéã«ããã€ãŠæžæ¿ç¶æ ãä¿æãã
ãããã€ãŠç²åã®å¯åºŠãã»ãŒïŒã«çããããšãèª
ããããããã®äžã«æ¬çºæã«ãã芪氎æ§ã©ããã¯
ã¹ç²åã¯å ç«åå¿æ§ãæãªããã«è¯å¥œã«é å¿åé¢
å¯èœã§ããããã€åæžæ¿å¯èœã§ããã äŸ 13 ãããã¬ãªãããã³ïŒTSHïŒãå®éãããã
ã®é µçŽ å ç«å®éïŒEIAïŒ ããè¡æž äžã®TSHã®æž¬å®ã¯ç²ç¶è ºçŸç ã®èšºæ
ã§èããéèŠã§ãããåºç€TSHæ¿åºŠã®èããäž
æã§ïŒæ¬¡ç²ç¶è ºæ©èœæžåŒ±ãèªããããããã®ä»è¡
æž äžã®TSHåºç€å€0.5ã3ÎŒUïŒmlãTRHïŒåºæ¿ã
ã«ã¢ã³æŸåºå åïŒã§åºæ¿åŸã«äžæããªãå Žåã«ç²
ç¶è ºæ©èœæžåŒ±ã¯ç¢ºå®ã«ããåŸãªããããã«å¯ŸããŠ
TSHå€ãå°ãªããšã2.5ÎŒUïŒmlãããã25ÎŒUïŒ
ml以äžã§äžæããå Žåã«ã¯ç²ç¶è ºç©è³ªä»£è¬ã¯é«ã
確çã§æãªãããŠããªãã25ÎŒUïŒmlãå ãã«äž
åã€ãåºç€å€ã®äžæã¯æœåšçãªçç¶çºçŸåã®ç²ç¶
è ºæ©èœæžåŒ±ãæšæž¬ããããšãã§ãããæ¢ã«TSH
ã®é µçŽ å ç«å®éã¯å ¬ç¥ã§ãããâã¯ãªãã«ã»ãã
ã«ã»ã¢ã¯ã¿ïŒClinica Chemica ActaïŒâã第67
å·»ã263ã268é ïŒ1976幎ïŒïŒâãšã³ãã€ãŒã¡ã»ã©ã
ã«ãã»ã€ã ãã¢ãã»ã€ã»ãªãã»ãã«ã¢ã³ãºã»ã¢ã³
ãã»ãã©ãã°ã¹ïŒenzyme labelled
immunoassay of hormones and drugsâã327ã
337é ãS.B.PalãWalter de Gruyterããã«ãªã³
ããã³N.Y.ïŒ1978幎ïŒïŒâã¢ããªãŠãŒãã«ã«ã»ããª
ã±ãã¹ããªïŒAnalytical BiochemistryïŒâ第96
å·»ã419ã425é ïŒ1979幎ïŒããããããããã®å ¬ç¥
ã®æž¬å®æ³ã¯ããããŠé·ãææž©ä¿ææéïŒïŒæ¥ãŸ
ã§ïŒãå¿ èŠãšããéæã§ã¯ãªãïŒTSH5ÎŒUïŒmlïŒ
ãŸãã¯é«äŸ¡ãªæž¬å®è£ 眮ïŒè¢å 枬å®è£ 眮ãŸãã¯çºå
枬å®è£ 眮ïŒãšåæãšãããã®éãã®ä»ã«ãããã
æ··åããããã®è£ 眮ãå¿ èŠã§ããã æ¬çºæã«ãã芪氎æ§ã©ããã¯ã¹ç²åã®äœ¿çšã¯ïŒ
1/2æ¥ã«ãããªãå šææž©ä¿ææéã§äºéæäœåé¢
æè¡ã«ããTSHã®æž¬å æ³ã«ãã枬å®ãå¯èœã«ã
ãããã®é第ïŒã®æäœãæ¬çºæã«ãã芪氎æ§ã©ã
ãã¯ã¹ç²åã«å ±æçµåãããã次ãã§çµåããã
é µçŽ æŽ»æ§ãïŒïŒŠâåé¢ã«ãã枬å®ãããã©ãã
ã¯ã¹ç²åã¯æ°Žã®å¯åºŠãããèããã¯é«ããªãå¯åºŠ
ãæããŠããã®ã§ãã©ããã¯ã¹ç²åã¯é µçŽ åå¿ã®
éãæžæ¿ç¶æ ã§ãããããã«ããåžžçšã®å Žåãç
ç¥ããããæäœã®é«ãè² è·å¯èœæ§ã®ããã«å¯èœã§
ããããããŠåžéãããã©ããã¯ã¹ç²åã䜿çšã
ãå Žåã«ã¯é µçŽ åå¿çµäºåŸã®ç²åã®é å¿åé¢ãç
ç¥ãããããããšããã®ãæžæ¿æ¶²ãééããŠæž¬å
ã§ããããã§ããã å ç«åŠçè©Šéšæ¹æ³ã§äžè¬ã«äœ¿çšãããã©ããã¯
ã¹ãšã¯ç°ãªãæäœãè² è·ããããæ¬çºæã«ãã芪
æ°Žæ§ããªã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬ãŒãç²åã¯é å¿å
é¢åŸå®¹æã«åæžæ¿ãããããšãã§ãããåãçç±
ããé µçŽ ã§æšèãããæåã®ããããŠå°ããéç¹
ç°çåžçã瀺ãããïŒç¬¬ïŒæäœã®äžåšã§ã®çµåã
ãã掻æ§ïŒã è©Šéšå®æœ TSHâæšæºïŒTSHäžå«è¡æž äžã®åœéåç §èª¿å€
MRC68ïŒ38ïŒ0.2mlãïŒïŒ150000ã§æ°ŽãŸãã¯å¥œé©
ãªç·©è¡æº¶æ¶²ã§åžéãããèªäœå ¬ç¥ã®ãäŸãã°ã¢ã«
ã¢ããã®æTSHâæè¡æž 0.1mlãšãšãã«ææž©ä¿æ
ããã12æéåŸã°ã«ã³ãŒã¹ãªãã·ããŒãŒïŒGODïŒ
ã«å ±æçµåããTSHïŒTSHçŽ1.5Ã10-9ïœã«çžåœïŒ
ããæãé µçŽ ã³ã³ãžãŠã²ãŒãã®æº¶æ¶²0.1mlã第ïŒ
å·¥çšã®æ··åç©ã«ããããã§æ·»å ããããã®æ··åç©
ã«æŽã«12æéåŸã©ããã¯ã¹æžæ¿æ¶²0.1mlãããã
ãã§æ·»å ããã該æžæ¿æ¶²ã¯ã¡ã¿ã¯ãªã¬ãŒãã©ãã
ã¯ã¹0.1ãïŒmgïŒmlãå«æãããã®éäŸ11ã«èšèŒ
ãããŠããããã«ä¹Ÿç¥ã©ããã¯ã¹ç²å1000mgã«ã€
ããã¢ã«ã¢ããâIgGã«å¯Ÿããã€ã®ã®æè¡æž ãã
åŸãããå ç«ã°ãããªã³ãã©ã¯ã·ãšã³ã®ããçœè³ª
ïŒã150mgãå ãããã€ããããŠèŠªæ°Žæ§ã©ããã¯
ã¹ç²åã«å ±æçµåããããïŒæéåŸé å¿åé¢ãã
ãã€ã©ããã¯ã¹ç²åã®æ²æŸ±ç©ã奜é©ãªç·©è¡æº¶æ¶²ïŒ
mlã§æŽããããã«ããã©ããã¯ã¹ç²åã¯åæžæ¿ã
ãããåŒç¶ãæ¹ããŠæ°åºŠé å¿åé¢ãããã€æŽæµã
ããäžæŸã¿æ¶²ãæ£ãŠãã åãããã«GODã®åºè³ªæº¶æ¶²ïŒmlãããããã§
å ¥ãããã€çæéæ¯çªããããã®åŸå°ãªããšãïŒ
æéã©ããã¯ã¹ç²åã¯åäžã«æžæ¿ããããŸãŸã§ã
ãã次ãã§æžæ¿æ¶²ãç®çãã¯ãããã«å ¥ãããã€
405nïœã§åžå 床ã枬å®ãããååžå 床ããåºè³ª
ç²æ€å€L1ãåŒããL1ã¯ãæTSHâæè¡æž ãšTSH
âGODãšã®æ··åç©ã«æ·»å ãããåèšã®ã©ããã¯
ã¹æžæ¿æ¶²ãšåãç©è³ªãè² è·ãããã©ããã¯ã¹ç²å
ãå«ãåºè³ªæº¶æ¶²ïŒmlã®åžå 床ã§ããã ããããŠæ±ããããåžå 床ãçš®ã ã®TSHæšæº
æ¿åºŠã«é¢ããŠèšé²ããããã®æ€éæ²ç·ãçšããŠèš
åºè©Šæäžã®æªç¥å«éã®TSHã®æ¿åºŠã枬å®ããåž
å 床ã«åºã¥ããŠèªã¿åãã 奜é©ãªç·©è¡æº¶æ¶²ãšããŠæå©ã«EDTA0.005ã¢ã«ã
ãŠã·è¡æž ã¢ã«ããã³0.1ïŒ äžŠã³ã«NaCl0.15ã¢ã«ã
å«ã0.04Mâãã¹ããšãŒã溶液ïŒPH7.4ïŒã䜿çš
ããã GODâåºè³ªæº¶æ¶²ãšããŠæå©ã«ã°ã«ã³ãŒã¹ïŒ
ïœïŒ100mlãïŒïŒ2â²âã¢ãžãâãžâãïŒâãšãã«â
ãã³ãºãã¢ãŸãã³âã¹ã«ãã³é ž(6)ãïŒABTSïŒ
100mgïŒ100mlããã«ãªãã·ããŒãŒïŒPODïŒïŒ
mgïŒ100mlã0.05Mâãã¹ããšãŒãç·©è¡æ¶²ïŒPH
5.6ïŒãå«ã氎溶液ã䜿çšããã æ¯èŒã®ããã«ïŒã€ã®è¡æž è©Šæã®TSHå«éãå
èšEIA(A)䞊ã³ã«å ¬ç¥ã®äºéæäœâRIA(B)ã§æž¬å®ã
ãã次衚ã«ç€ºãéããããã枬å®å€ã¯è¯ãäžèŽã
ãïŒ (A) (B) è¡æž ïŒ 11.2ÎŒUïŒml 12.5ÎŒUïŒml ïŒ 7.3ÎŒUïŒml 7.1ÎŒUïŒml è¡æž ïŒ 3.8ÎŒUïŒml 4.5ÎŒUïŒml åèšã®TSHâ枬å®ããããæ¬çºæã«ãã芪氎
æ§ã©ããã¯ã¹ç²åãçç©åŠçããã³ïŒãŸãã¯å ç«
åŠçã«æŽ»æ§ãªç©è³ªãç¹ã«æäœã®ãã€ãªã€ãšããŠã
ãããŠå¥œé©ã§ããããšãåŸãããã éç¹ç°ççµåã®æž¬å® TSHæšæºè©Šæãåèšã®è©Šéšå®æœã®é ç®ã§èšèŒ
ãããããã«ããŠåŠçãïŒè©ŠæïŒããã€ã»ãšã
ã©è©Šæãšåãåå¿ã«ãããããåæ§ã®è©ŠæïŒè©Š
æïŒãšæ¯èŒãããæTSHâæè¡æž ã®ã¿ã¯çã
ããè©ŠæãšïŒ€ã®æžæ¿æ¶²ã§æž¬å®ãããåžå 床ã®æ¯
èŒã¯éç¹ç°ççµåã1.5ïŒ ãããå°ããããšã瀺
ãã ãè¡šã
é¢ããã ç¹ã«è¿ éãã€ç°¡åã«å®æœãããã€ãã°ãã°è£žçŒ
ã§èŠ³å¯ããããšãã§ããããã«å ç«åŠã§å€ãã®èšº
æ枬å®ã®ç¯å²å ã§å©çšãããæåæäœè€åç©ã®å
éåå¿ã«ã¯å ç«åŠçã«æŽ»æ§ãªç©è³ªãäŸãã°æäœã®
ãã€ãªã€ãšããŠçæ°Žæ§ã©ããã¯ã¹ç²åãé·ãé䜿
çšãããŠããããã®çæ°Žæ§ã©ããã¯ã¹ç²åã¯å€§ãŠ
ãã¯ããªã¹ãã¬ã³ãã¢ããªããŒãŸãã¯ã³ããªã
ãŒãäŸãã°ã¹ãã¬ã³ïŒãã¿ãžãšã³ã³ããªããŒãŸã
ã¯ã¢ã¯ãªã«ãããªã«ïŒãã¿ãžãšã³ïŒã¹ãã¬ã³ã³ã
ãªããŒïŒABSïŒããæãããã€ãšãã«ãžãšã³é
åã«ãã補é ãããã é·ãéç¥ãããŠãããšãã«ãžãšã³éåã§ã¯ãäž
è¬ã«ïŒæåãæ·»å ãããïŒæ°Žã«é£æº¶æ§ã®ã¢ãããŒ
ãŸãã¯æ°çš®ã®æ°Žã«é£æº¶æ§ã®ã¢ãããŒã®æ··åç©ã
æ°Žãä¹³åå€ããã³æ°Žæº¶æ§éå§å€ãã¢ãããŒã¯ä¹³å
å€ã«ãã€ãŠå°æ»Žã®åœ¢ç¶ã«æ¶²åããããã®éå€æ°ã®
ä¹³åå€ååã®äŒåã«ãã€ãŠäžã§ãäžéšã¯ç©ºã®ãã
ã€äžéšã¯ã¢ãããŒååã«ãã€ãŠæºãããã倧ããª
ãã»ã«ã圢æããããåŸè ã¯ã¢ãããŒã®âå¯æº¶
æ§âãšããŠç€ºãããã氎溶æ§éå§å€ã¯ãæ°Žçžã®å
ã¢ãããŒååã®éåããŸãã¢ãããŒã§æºãããã
ãã»ã«ã§äžŠã³ã«ã¢ãããŒæ»Žã§éåãéå§ãããã¯
掻æ§åããããšã®ã§ããã©ãžã«ã«ã圢æãããã
ããå®éã«ã¯éåã¯èšæœ€ãããã»ã«ã§èµ·ãããã
ãšããã®ãäžæ¹ã§ãã»ã«äžã®ã¢ãããŒæ¿åºŠãåšå²
ã«ãããåã ã®æº¶ããã¢ãããŒååã®æ¿åºŠããã
èãã倧ããããŸãä»æ¹ã§ãã»ã«ã®æŽ»æ§åã®ç¢ºç
ãã¢ãããŒæ»Žã®æ°ã«æ¯ã¹ãŠãã»ã«ã®æ°ãå€ããã
ã«ããããŠé«ãããã§ãããå å¡«ãã»ã«ã®çŽåŸã¯
éåäžã«ãã»ã«ãæçµçã«çç¶ã®ã©ããã¯ã¹ç²å
ã«ç§»è¡ãããŸã§å¢å€§ããã掻æ§åãããªããã»ã«
ã®ä¹³åå€ååããã³æ¶è²»ãããã¢ãããŒæ»Žã®è¡šé¢
ããã®ä¹³åå€ååã¯ã©ããã¯ã¹ç²åã®è¡šé¢ããã
ãããã€çæããããªããŒåæ£æ¶²ã®å®å®åã«åœ¹ç«
ã€ã äŸãã°çé¢æŽ»æ§å€ãŸãã¯æ¹¿æœ€å€ã§ãã€ãŠããä¹³
åå€ãŸãã¯ãšãã«ãžãšã³å®å®å€ã®æ·»å äžã«å ¬ç¥æ¹
æ³ã«ãã補é ãããã©ããã¯ã¹ã¯æ¬¡ã®æ¬ ç¹ãæã€
ãŠããããããã®æ¬ ç¹ã¯ç¹ã«å ç«åŠçã«æŽ»æ§ãªç©
質ã®ãã€ãªã€ãšããŠã®äœ¿çšããã³é£ç¶çãªæº¶æ¶²æž¬
å®ç³»ã§ã®äœ¿çšã劚ããïŒ ïŒ ã©ããã¯ã¹ç²åã®çæ°Žæ§è¡šé¢ã«ææã®å ç«åŠ
çã«æŽ»æ§ãªç©è³ªãäŸãã°æäœã®ä»ã«éç¹ç°çã«
å€æ°ã®ä»ã®è¡æž æåãçµåããïŒ ïŒ å ±æçµåã«ãããåžççã«ã®ã¿çµåããå ç«
åŠçã«æŽ»æ§ãªç©è³ªã¯èšºæè©Šéšã®çµéã®äžã§æž¬å®
äžã«åã³åé¢ããå ŽåãããïŒ ïŒ ãšãã«ãžãšã³éåã§ä¹³åå€ãŸãã¯å®å®å€ãšã
ãŠäœ¿çšãããçé¢æŽ»æ§å€ã氎溶液äžã«æ¡æ£ããŠ
çç©åŠçã«æŽ»æ§ãªããçœè³ªã®æ§é ãããããã€
ãŠæŽ»æ§ãç Žå£ããå ŽåãããïŒ ïŒ å®å®åäœçšãæããçé¢æŽ»æ§å€ãé€ãéã«ã©
ããã¯ã¹æžæ¿æ¶²ãåéãããã€é å¿åé¢ã®éã«
ãå®å®æ§ãããããããã®éçæããæ²æŸ±ç©ã¯
åæžæ¿ãããŠåã®ç¶æ ã«ããã®ãããããŠå°é£
ããŸãã¯ãã¯ãå¯èœã§ã¯ãªãã ãããã®æ¬ ç¹ãåé¿ããããã«æ¢ã«çš®ã ã®ææ¡
ããªããããããããã¯åžžã«åèšã®åé¡ã®äžéšã®
ã¿ã解決ãåŸãã«ããªãã€ãã ã«ã«ããã·ã«åABSâã³ããªããŒããã³ã«ã«
ããã·ã«åã¹ãã¬ã³ïŒãã¿ãžãšã³ã³ããªããŒãã
æããç²åºŠ0.01ã0.9ÎŒïœã®çæ°Žæ§ã©ããã¯ã¹ç²å
ã西ãã€ãåœç¹èš±å ¬å第2203377å·å ¬å ±ããå ¬ç¥
ã§ããããããã¯è¡æž åŠçã«äžæŽ»æ§ã®ãã€ãªã€ãš
ããŠçç©åŠçã«æŽ»æ§ãªããçœè³ªã«å¯ŸããŠäœ¿çšã
ãããã®éããçœè³ªã¯ãã€ãªã€ã«ãã©ããã¯ã¹äž
ã«å°å ¥ãããã«ã«ããã·ã«åºãä»ããŠã¢ããçµå
ã®åœ¢æäžã«å ±æçµåãããã 西ãã€ãåœç¹èš±å ¬é第2812845å·å ¬å ±ããABS
âã³ããªããŒããæããç²åºŠ0.05ã1ÎŒïœã®çæ°Žæ§
ã©ããã¯ã¹ãå ¬ç¥ã§ããããã®å Žåã«ãã©ããã¯
ã¹ã¯ã«ã«ããã·ã«åºã§å€æ§ããããã€åå¿æ§åŽé
ãšçž®åããŠããããã®ããã«å ç«åŠçã«æŽ»æ§ãªç©
質ãå ±æçµåã§ããã ãã®å ¬ç¥ã®çæ°Žæ§ã©ããã¯ã¹ã«ãã€ãŠåèšã®ç¬¬
ïŒã®åé¡ã¯è§£æ±ºããããä»ã®ãã¹ãŠã®æ¬ ç¹ã¯çžå€
ãããååšããã ãããã€ãŠçæ°Žæ§ã©ããã¯ã¹ã®ä»£ããã«èŠªæ°Žæ§
ã²ã«ãå ç«åŠçã«æŽ»æ§ãªç©è³ªã®ãã€ãªã€ãšããŠäœ¿
çšããããšãè©Šã¿ãããã芪氎æ§ã²ã«ã¯åžçæ§ã
å šããŸãã¯ããããŠå ãããæãããä»æ¹ããçœ
質ã®ãããã²ã«ãžã®å ±æçµåã¯å ¬ç¥ã§ããã®ã§ã
ãã®è£œæ³ããã³ç²åºŠã«åºã¥ããŠâã©ããã¯ã¹âãš
瀺ããŠãããâãã€ã¯ãã²ã«âãææ¡ããããã
ãã芪氎æ§ã©ããã¯ã¹ã¯äŸãã°ç±³åœç¹èš±ç¬¬
4138383å·æ现æžããå ¬ç¥ã§ããã該ã©ããã¯ã¹
ã¯0.35ÎŒïœãããå°ããªçŽåŸãæããç圢ç²åã
ãæããã©ãžã«ã«ã«ãã€ãŠéå§ãããæ°Žæ§ãšãã«
ãžãšã³éåã®æ¡ä»¶äžã«è£œé ããããã®éã¢ãããŒ
ãšããŠã¢ã¯ãªã«ã¢ãããã¢ã¯ãªã«é žãã¡ã¿ã¯ãªã«
é žãŸãã¯ã¢ã¯ãªã¬ãŒãã䜿çšããããä¹³åå€ãšã
ãŠã¯äŸãã°éå±ç³ããã䜿çšããããããããŠåŸ
ããã芪氎æ§ãã€ã¯ãã²ã«ã«çç©åŠçããã³ïŒãŸ
ãã¯å ç«åŠçã«æŽ»æ§ãªç©è³ªãèªäœå ¬ç¥ã®æ¹æ³ã§ã«
ã«ããžã€ããâããªããžãŸãã¯ã°ã«ã¿ã«ãžã¢ã«ã
ããâããªããžãä»ããŠå ±æçµåãããããã«ã
ã€ãŠåèšã®ç¬¬ïŒãšç¬¬ïŒã®åé¡ã解決ããããã第
ïŒãšç¬¬ïŒã®åé¡ã¯è§£æ±ºãããªãããããšããã®ã
ãšãã«ãžãšã³éåã¯çžå€ããä¹³åå€ãŸãã¯å®å®å€
ã®æ·»å äžã«å®æœããªããã°ãªããªãããã§ããã æ¬çºæã®èª²é¡ã¯ãåèšã®ïŒã€ã®æ¬ ç¹ãã¹ãŠãå
é¿ããããšã®ã§ãã芪氎æ§ã©ããã¯ã¹ãå«æãã
蚺æè¬ãèŠãåºãããšã§ããããããã€ãŠæ¬çºæ
ã®èª²é¡ã¯ãç¹ã«çç©åŠçããã³ïŒãŸãã¯å ç«åŠç
ã«æŽ»æ§ãªç©è³ªãå ±æçµåããããšãã§ããçç©åŠ
çã«æŽ»æ§ãªããçœè³ªã®æ§é ããããã€ãŠæŽ»æ§ãæ
ãªããããã®å®å®æ§ãé å¿åé¢ã®éã«ããããã
ãã€åéãããã€åŒç¶ãåã³å®¹æã«æžæ¿ãããã
ãšã®ã§ãã芪氎æ§ã©ããã¯ã¹ç²åãå«æãã蚺æ
è¬ãèŠåºãããšã§ããã ãã®èª²é¡ã¯æ¬çºæã«ããã°æ°Žã«é£æº¶æ§ã®ã¢ãã
ãŒã®ãã¢ããªããŒãŸãã¯ã³ããªããŒããæã芪氎
æ§ã©ããã¯ã¹ç²åãå«æãã蚺æè¬ã«ãã€ãŠè§£æ±º
ãããã該芪氎æ§ã©ããã¯ã¹ç²åã¯æ°Žæº¶æ§ã®ãã©
ãžã«ã«ã圢æããéå§å€ã®ååšã§ããããä¹³å
å€ãå®å®å€ãŸãã¯æ¹¿æœ€å€ãæ·»å ããã«ãšãã«ãžãš
ã³éåã«ãã€ãŠè£œé å¯èœã§ããããã€ãã¢ããªã
ãŒã®å Žåã«ã¢ãããŒãããããã¯ã³ããªããŒã®å Ž
åã«ã¢ãããŒé¡ã®äžéšãååäžã«å°ãªããšãïŒå
ã®éåå¯èœãªïŒ£ïŒïŒ£âäºéçµåãæãããšããã·
ãã§ããã ææ³å€ã«ãåé ã§åŒçšãããå ¬ç¥æè¡ã«ãèšè¿°
ãããŠãããåœæ¥çã§é·ãéæ¯é çã§ãã€ãææ³
ã«åããŠä¹³åå€ãå®å®å€ãŸãã¯æ¹¿æœ€å€ã®æ·»å ããš
ãã«ãžãšã³éåã®å®æœã«ãŸã€ããå¿ èŠã§ã¯ãªãã
ãšã瀺ãããããããã€ãŠãä¹³åå€ãšããŠäœ¿çšã
ããéå±ç³ãããŸãã¯çé¢æŽ»æ§å€ã¯ã©ããã¯ã¹ç²
åããæ¡æ£ãããã€ã©ããã¯ã¹ç²åã«å ±æçµåã
ãããçœè³ªã®çç©åŠç掻æ§ãæãªããŸãã¯å®å šã«
ç Žå£ããããã«åŸæ¥ã¯ç¡æ¡ä»¶ã«å¿ èŠã§ãã€ããã
ãªããŒã®ã©ããã¯ã¹ç²åããã®å€§ãŠãã¯ããããŠ
å°é£ãã€ç ©éãªä¹³åå€ã®é€å»ãçç¥ãããã å°ãªããšãïŒåã®éåå¯èœãªäºéçµåãå«ãã°
ãªã·ãžã«ååç©ãã¢ãããŒãšããŠäœ¿çšããã®ãã
ãããŠæå©ã§ãããšç€ºãããã該ååç©ã®æ§é ã¯
éåæ§ã®äºéçµåäžã«çæ°Žæ§éšåããã³ãšããã·
ãåºããªãã·ã©ã³ç°äžã«åæã«èŠªæ°Žæ§éšåãæã
ããçæããã©ããã¯ã¹æžæ¿æ¶²ã¯ä¹³åå€ãå®å®å€
ãŸãã¯æ¹¿æœ€å€ã®äžåšã«ããããããåéããªãã
ã©ããã¯ã¹æžæ¿æ¶²ã®å®å®åã¯é å¿åé¢ã®éã«ãã
ããããªããæ«ç«¯ãšããã·ãåºã¯çš®ã ã®åå¿ïŒå
æ°Žå解ãã¢ã³ã¢ããªã·ã¹ãã¢ãããªã·ã¹ãçž®åïŒ
ãããããŠåãæãã®ã§ãšããã·ãåºã¯ååæ£ç³»
ã«åæ£ããã©ããã¯ã¹çäœã®è¡šé¢ã該ãšããã·ã
åºãæ°Žçžæ¹åã«é åãããããã«ããã€ãŠããã«
ã¡ãããªãã ã¢ãããŒãšããŠã¯æå©ã«ã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬
ãŒããã°ãªã·ãžã«ã¢ã¯ãªã¬ãŒããã°ãªã·ãžã«ãã
ã«ãšãŒãã«ãã°ãªã·ãžã«ããã«ãã¿ã¬ãŒãããã³
ïŒïŒïŒâãšããã·ãã(1)ãšã³ã䜿çšãããããã®
éãããã®ã¢ãããŒã®ïŒçš®ãå°ã䜿çšãããã®çµ
æãçæãã芪氎æ§ã©ããã¯ã¹ç²åã¯ãã¢ããªã
ãŒã§ãããããããã®ã¢ãããŒã®æ··åç©ãå ±éå
ããŠãããã ãšããã·ãåºã®å«éãå¶åŸ¡ããããã«åèšã®ã°
ãªã·ãžã«ååç©ïŒçš®ãŸãã¯æ°çš®ãšäžç·ã«ä»ã®ã¢ã
ããŒãäŸãã°ã¹ãã¬ã³ããžãšã³ãã¢ã¯ãªã«ã¢ã
ããã¡ã¿ã¯ãªã«ã¢ãããã¢ã«ãã«âãããããã·
ã¢ã«ãã«âããã³ã¢ããã¢ã«ãã«ã¢ã¯ãªã¬ãŒãã
ã¢ã«ãã«âãããããã·ã¢ã«ãã«âããã³ã¢ãã
ã¢ã«ãã«ã¡ã¿ã¯ãªã¬ãŒããããã«ãšãŒãã«ããã
ã«ãšã¹ãã«ãâããã«ãããªãã³çãå ±éåã
ãããšãã§ããã çè²æãŸãã¯è¢å æ§ååç©ãäŸãã°ãã«ãªã¬ã»
ã€ã³ã®ã¢ãããŒã®éåæ§èªå°äœã®ååšã§éåããŠ
ãããããã®ããã«ããŠãããŸãã¯åç©ã®çµç¹ã§
æåãããã¯æäœãæ€åºããããã«å¥œé©ã§ããç
è²ããããããã¯è¢å æ§ã®ã©ããã¯ã¹ç²åãåŸã
ããããã®æ€åºæ¹æ³ã¯çµç¹åŠã§çµç¹æçã補é ã
ãã®ã«ç¹ã«å¥œé©ã§ãããã¢ãããŒã®éåæ§èªå°äœ
ãšããŠã¯æå©ã«çè²æãããã¯è¢å æ§ååç©ã䜿
çšããããã®äžã«èªäœå ¬ç¥ã®æ¹æ³ã§ã¡ã¿ã¯ãªã«åº
ãããã¯ã¢ã¯ãªã«åºãå°å ¥ãããã çæããã©ããã¯ã¹ç²åã®æ°Žã«å¯Ÿããé£æº¶æ§ã
é«ããããã«ãšãã«ãžãšã³éåäžã«åžžçšã®æ¶æ©
å€ãäŸãã°ã¢ã«ãã¬ã³âãŸãã¯ããããã·ã¢ã«ã
ã¬ã³ãžã¢ã¯ãªã¬ãŒããã¢ã«ãã¬ã³âãŸãã¯ããã
ãã·ã¢ã«ãã¬ã³ãžã¡ã¿ã¯ãªã¬ãŒããã¢ã«ãã¬ã³ã
ã¹ã¢ã¯ãªã«ã¢ãããŸãã¯ã¢ã«ãã¬ã³ãã¹ã¢ã¯ãªã«
ã¡ã¿ã¯ãªã«ã¢ããããžããã«ãã³ãŒã³çãæ·»å ã
ãŠãããã éå§å€ãšããŠãšãã«ãžãšã³éåã§åžžçšã®æ°Žæº¶æ§
éå§å€ã䜿çšããããšãã§ãããæå©ã«ãã«ãªã
ãœãžã¹ã«ããšãŒãããã«ãªããœãã¬ãŒããéé žå
æ°ŽçŽ ãŸãã¯å¥œé©ãªã¬ããã¯ã¹ç³»ã䜿çšãããã æ°Žã«é£æº¶æ§ã®ã¢ãããŒïŒçš®ãŸãã¯æ°çš®ãä¹³åå€
äžå«ã®ãšãã«ãžãšã³éåã«ãã芪氎æ§ã©ããã¯ã¹
ç²åã補é ããããã®æ¹æ³ã¯ç©ºäžé žçŽ ãããã¯é
é¢ã®é žçŽ ã«å¯ŸããŠææã§ããããããã€ãŠé žçŽ ã
ãã¹ãŠã®ããªããŒæåããã³å®¹åšããååãªç ®
沞ãäžæº¶æ§ã¬ã¹é°å²æ°äžã«ãããèžæºãŸãã¯çª
çŽ ãã¢ã«ãŽã³ãŸãã¯ä»ã®äžæŽ»æ§ã¬ã¹ã®å°éã«ãã
ããããŠæ éã«é€å»ããªããã°ãªããªãã ä¹³åå€äžå«ã®ãšãã«ãžãšã³éåã¯æå©ã«æ°Žçžå¯Ÿ
ã¢ãããŒçžã®æµŽæ¯ã容éã«é¢ããŠïŒïŒïŒã16ïŒïŒ
ã§å®æœããã æ°Žçžã«æº¶ããéå§å€ã®æ¿åºŠã¯æå©ã«0.5ã1.5
ïœïŒã§ããããã€ã¢ãããŒçžäžã®ãšããã·ãã®
æ¿åºŠã¯æå©ã«ïŒã100ééïŒ ã§ããã ãšãã«ãžãšã³éåã¯æå©ã«æž©åºŠïŒã80âã§å®æœ
ããã枩床ã¯éžæãããéå§å€ã«äŸåããããã«
ãªããœäºç¡«é žã«ãªãŠã ã®äœ¿çšã®éã«ã¯æå©ã«60ã
70âã§äœæ¥ãããåæ§ã«åå¿æéã¯éå§å€ã®éžæ
ã«äŸåããïŒã40æéã§ããã 芪氎æ§ã©ããã¯ã¹ç²åã¯å³å¯ã«ç圢ã§ãååæ£
ç³»ã§åæ£ããããã€çŽåŸ0.15ã1.5ÎŒïœã®äºãã«ã»
ãŒåã倧ããã®ç²åã§ããã 芪氎æ§ã©ããã¯ã¹ç²åã¯ãšãã«ãžãšã³éåçµäº
åŸå°éåãããªãã¢ãããŒã®æ®åãå«ãã§ããå Ž
åãããããã®æ®åã¯æ°Žèžæ°èžæºãŸãã¯éæã«ã
ãé€å»ããããšãã§ããããã®å Žåã«ãé å¿åé¢
ã«ããã©ããã¯ã¹ç²åãå®å®æ§ãããããã«æ²é
ãããããšãã§ãããã®çµæåŒç¶ãååæ£ããã
ãšãã§ããã芪氎æ§ã©ããã¯ã¹ç²åã®ç¹ã«æå©ãª
æ§è³ªã¯ä¿æãããããã®ããã«ããŠæ¬çºæã«ãã
ã©ããã¯ã¹ã¯æ°åºŠã®é å¿åé¢ããã³ãã«ã³ããŒã·
ãšã³ã«ãã€ãŠç°¡åã«ç²Ÿè£œããããšãã§ããã ã©ããã¯ã¹ã®æ«ç«¯ã®éé¢ãšããã·ãåºã¯çš®ã ã®
ååŠç©è³ªã«å¯ŸããŠé«åå¿æ§ã§ããããããã€ãŠå®¹
æã«å æ°Žå解ã§ããéãšãŠçŽ é žå¡©ãããã¯éãšãŠ
çŽ é žãçšããŠé žåããŠã¢ã«ãããåºã«ããã¢ã³ã¢
ãã¢ã第ïŒã¢ãã³ããžã¢ãã³ãŸãã¯ããã©ãžã³ãš
åå¿ãããŠç¬¬ïŒãŸãã¯ç¬¬ïŒã¢ããåºã«ãããŸãã¯
ä»ã®å ¬ç¥ã®åå¿ãçšããŠå€æ§ããããšãã§ããã
ã©ããã¯ã¹ã®ãšãã«ãžãšã³ã¯ä¹³åå€ãæ¬ ããŠãã
ã«ãããããããšããã·ãåºã®å€æ§ãææã«ãã
ãšãã«ãžãšã³éåã®éãå®æœãåŸãã»ã©é«ãå®å®
æ§ãæãããã®ããã«æ¢ã«éååå¿ããè¡šé¢ãäŸ
ãã°ç¬¬ïŒã¢ããåºã§å€æ§ãããã©ããã¯ã¹ãçæ
ããã次ãã§å€æ§ãããããŸãã¯èªå°äœåããã
ãšããã·ãåºã¯ããã€ãªã€ãšããŠäœçšãã芪氎æ§
ã©ããã¯ã¹ç²åã«å ±æçµåãããçç©åŠçã«ãã
ã³ïŒãŸãã¯å ç«åŠçã«æŽ»æ§ãªããçœè³ªãšã®âçµå
ïŒKupplungïŒâã«äœ¿çšãããã åèšã®èª²é¡ã¯èŠªæ°Žæ§ã©ããã¯ã¹ç²åãçç©åŠç
ããã³ïŒãŸãã¯å ç«åŠçã«æŽ»æ§ãªç©è³ªã®è¡æž åŠç
ã«äžæŽ»æ§ãªãã€ãªã€ãšããŠãäŸãã°ãããããã
ãçœè³ªãé µçŽ ããã«ã¢ã³ããã¿ãã³ãæåãæäœ
ããã³åŸ®çç©ã®ãã€ãªã€ãšããŠäœ¿çšããããšã«ã
ã解決ãããã æ¬çºæã®ç®çã¯ãã€ãªã€ãšããŠèŠªæ°Žæ§ã©ããã¯
ã¹ç²åããã³ãã®ãã€ãªã€ã«çŽæ¥ãŸãã¯âããªã
ãžâãšããŠã®çµåå€ãä»ããŠå ±æçµåãããçç©
åŠçããã³ïŒãŸãã¯å ç«åŠçã«æŽ»æ§ãªåèšã®ç©è³ª
ãå«ã蚺æè¬ã§ããã æ¬çºæã«ãã蚺æè¬ã¯åäœå çŽ æšèå ç«å®éæ³
ïŒRIAïŒãé µçŽ å ç«å®éæ³ïŒEIAïŒããã³ãããã
ELISAïŒé µçŽ çµåå ç«åžçå®éæ³ïŒã§äœ¿çšããã®
ã«ç¹ã«å¥œé©ã§ããã äŸ ïŒïŒåèïŒ ãã«ãªããœäºç¡«é žã«ãªãŠã ïŒK2S2O8ïŒ0.08ïœ
ãèžæºæ°Ž80mlã«æº¶ããããã€ïŒåéçªçŽ ãå°éã
ããããšã«ãã空äžé žçŽ ãæé€ãããåæã«ã°ãª
ã·ãžã«ã¡ã¿ã¯ãªã¬ãŒã10mlããåæ§ã«ç©ºäžé žçŽ ã
é€ããïŒæåãã¬ã©ã¹åå¿åšã«å ¥ãããã€æŽã«10
åéçªçŽ ã§åŠçããã次ãã§åå¿åšãéãããã€
åå¿ã枩床65âã§äžæã«æ¹æäžã«ïŒæéå®æœã
ãããã®æéã®åŸå€æçã¯98ïŒ ã§ãããåå¿çæ
ç©ã¯çŽåŸ0.44ÎŒïœã®ç圢ã®ãååæ£ç³»ã«åé ãã
ãããªã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬ãŒãç²åããæãã©
ããã¯ã¹ã§ããã äŸ ïŒïŒåèïŒ äŸïŒãšåæ§ã«ããŠK2S2O80.08ïœã溶ãããèž
æºæ°Ž160mlããã³ã°ãªã·ãžã«ã¡ã¿ã¯ã¬ãŒã15éé
ïŒ ãšã¹ãã¬ã³85ééïŒ ã®æ··åç©10mlãå¥åã«é žçŽ
ãæé€ãããã€æž©åºŠ65âã§äžæã«æ¹æäžã«ïŒæé
äºãã«åå¿ããããå€æçã¯71.6ïŒ ã§ãããéå
ããªãæ®éã¢ãããŒãæ°Žèžæ°èžæºã«ããé€ããç
ããååæ£ç³»ã³ããªããŒã®ã©ããã¯ã¹ç²åã¯çŽåŸ
0.22ÎŒïœãæããã äŸ ïŒïŒåèïŒ äŸïŒãšåæ§ã«ããŠãèžæºæ°Ž100mläžã®
K2S2O80.1ïœã®æº¶æ¶²ããã³ã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬
ãŒã15ééïŒ ãšé ¢é žããã«85ééïŒ ã®æ··åç©10ml
ãäºãã«åå¿ããããå€æçã¯80ïŒ ã§ãããæ®é
ã¢ãããŒãæ°Žèžæ°èžæºã«ããé€ããçæããã©ã
ãã¯ã¹ã¯çŽåŸ0.16ÎŒïœã®ååæ£ç³»ãç圢ç²åã§ã
ãã ããããŠè£œé ãããã©ããã¯ã¹100mlã0.1Mâ
NaOH溶液100mlãšæ··åãããã€æž©åºŠçŽ25âã§24
æéæŸçœ®ãããå æ°Žå解äžããã³åŸãã©ããã¯ã¹
ã®å®å®æ§ã¯ä¿æãããããšãã«ãžãšã³ãé å¿åé¢
ããäžæŸã¿ããã«ã³ããŒã·ãšã³ãããã€åºäœçžã
åã³æ°Žäžã«åæ£ããããé å¿åé¢ããã³ååæ£ã
ïŒåºŠç¹°è¿ããçããäžæ§ãšãã«ãžãšã³ãïŒïŒâ
H2SO4ã§PHïŒã«ãããã€éãšãŠçŽ é žããšããã·
ãåºãšåœéã§å ãããé žåã¯25âã§çŽ24æéè¡ãª
ããåŒç¶ãæªåå¿äœååç©è³ªãéæã«ãã€ãŠé€
ããå®å®ãªãšãã«ãžãšã³ã®å€æ§ã©ããã¯ã¹ç²åã¯
ã¢ã«ãããåº2.8ééïŒ ãŸãã¯0.97ããªã¢ã«ïŒïœ
ãå«æããã äŸ ïŒïŒåèïŒ äŸïŒã®ããã«ããŠèžæºæ°Ž100mläžã®K2S2O80.1
ïœã®æº¶æ¶²ããã³ã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬ãŒã15éé
ïŒ ãšã€ãœãã¬ã³85ééïŒ ã®æ··åç©10mlã枩床65â
ã§24æéåå¿ããããå€æçã¯76ïŒ ã§ãããåŒç¶
ãæ®éã¢ãããŒãæ°Žèžæ°èžæºã«ããé€ãããã®é
çŽåŸ0.25ÎŒïœã®å®å®ãªãååæ£ç³»ã«åæ£ããç圢
ã®ã©ããã¯ã¹ç²åãçããã åŒç¶ããã®ãšãã«ãžãšã³100mlã«ã¢ã³ã¢ãã¢æ°Ž
溶液ïŒ25ïŒ ïŒ100mlãå ãããã€å®€æž©ã§24æéæŸ
眮ãããã®éãšããã·ãåºãã¢ã³ã¢ããªã·ã¹ã«ã
ã€ãŠã¢ããåºã«å€ãããåŒç¶ãåå¿çæç©ãéãš
ãŠçŽ é žã§åŠçãããã®éã¢ã«ãããåº4.5ééïŒ
ãŸãã¯1.55ããªã¢ã«ïŒïœãå«æããã©ããã¯ã¹ã
çããã äŸ ïŒïŒåèïŒ äŸïŒã®ããã«ããŠæ°Ž1.5äžã®K2S2O81.5ïœã®æº¶
液ããã³ã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬ãŒã15mlãå¥åã«
é žçŽ ãé€ãããã€äºãã«åå¿ããããæŽã«é žçŽ äž
å«ã®ã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬ãŒã120mlãé žçŽ æé€
äžã«ïŒæéã®éåå¿å®¹åšã«é£ç¶çã«æ»Žäžããã次
ãã§æŽã«30åééåãç¶ãããå€æçã¯85ïŒ ã§ã
ãããã€çæããç²åã¯çŽåŸ1.1ÎŒïœãæããã äŸ ïŒïŒåèïŒ äŸïŒã®ããã«ããŠã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬ãŒãïŒ
ééïŒ ãšã¹ãã¬ã³99ééïŒ ã®æ··åç©10mlããã³èž
æºæ°Ž100mläžã®K2S2O80.1ïœã®æº¶æ¶²ã65âã§22æ
ééåãããã®éçŽåŸ0.5ÎŒïœã®èŠªæ°Žæ§ã©ããã¯ã¹
ç²åãçæãããå€æçã¯90ïŒ ã§ããã äŸ ïŒïŒåèïŒ äŸïŒã«ãã補é ãããã©ããã¯ã¹æžæ¿æ¶²20mlã
2Nâèæ§ãœãŒã液ïŒmlãšãšãã«äžå€ã«ããã€ãŠ
宀枩ã§æ¹æãã次ãã§ïŒæéæ°Žã«å¯ŸããŠéæã
ããæ®æºããæžæ¿æ¶²ãéãšãŠçŽ é žãããªãŠã 100
mgã®æ·»å ã«ããPHïŒã«èª¿ç¯ãããã€äžå€ã«ããã€
ãŠå®€æž©ã§æ¹æãã次ãã§ïŒæéèžæºæ°Žã«å¯ŸããŠé
æããã äŸ ïŒïŒåèïŒ äŸïŒã«ãã補é ãããã©ããã¯ã¹æžæ¿æ¶²20mlã
æ¿ã¢ã³ã¢ãã¢æº¶æ¶²10mlãšãšãã«å®€æž©ã§20æéæ¹æ
ãããã€æµæ°Žã«å¯ŸããŠ48æééæãããåŸããã
æžæ¿æ¶²ãé å¿åé¢ããã也ç¥ç©è³ªã®çªçŽ å«éã¯çŽ
ïŒïŒ ã§ãããããã¯åçŽ10ã®ãšããã·ãåäœã®ã¢
ããåã«çžåœãããããè¡šé¢ã®åªããåå¿ã§ã¯ç¢º
å®ã«ããé«ãèªå°äœå床ã«çžåœãããé å¿åé¢ã
ããåºäœç©è³ªã0.1Nâèæ§ãœãŒã液20mlã§åžå
ãããããã«æ¹æäžã«ãžã¡ãã«ãã«ã ã¢ããïŒml
ã«æº¶ãããã³ãã¯é žããããã·ãµã¯ã·ã³ã€ãããš
ã¹ãã«âã¢ããã¢ã»ãã¢ã«ãããâã¢ã»ã¿ãŒã«
1.5ïœã滎äžãããçæããæžæ¿æ¶²ãæŽã«ïŒæé
æ¹æãã次ãã§1Nâå¡©é žã§PHïŒã«ãããã€æµã
ãèžæºæ°Žã«å¯ŸããŠ12æééæããã äŸ ïŒïŒåèïŒ äŸïŒã«ãã補é ãããã©ããã¯ã¹æžæ¿æ¶²20mlã«
Na2Sã»9H2O0.5ïœãå ãããã€å®€æž©ã§ïŒæ¥æ¹æ
ãããåŒç¶ãæžæ¿æ¶²ã®èãããªããªããŸã§æµãã
èžæºæ°Žã«å¯ŸããŠéæãã次ãã§æžæ¿æ¶²ãé å¿åé¢
ããã也ç¥ç©è³ªã¯ã€ãªãŠçŽïŒïŒ ãæããããã¯çŽ
10ã®ãšããã·ãåäœã®èªå°äœåã«çžåœããè¡šé¢ã§
ã®åªããåå¿ã§ã¯ç¢ºå®ã«ããé«ãèªå°äœå床ã«çž
åœããã é å¿åé¢ãããçæç©ã«ãžã¡ãã«ãã«ã ã¢ãã
ïŒmlã«æº¶ãããïŒâãã¬ã€ã³ã€ãããããµã³é žã
ãããã·ãµã¯ã·ã³ã€ãããšã¹ãã«ïŒïœãå ãã宀
æž©ã§ïŒæéæ¹æãã次ãã§æµããèžæºæ°Žã«å¯ŸããŠ
12æééæããã äŸ 10 ã©ããã¯ã¹âγâã°ãããªã³ã³ã³ãžãŠã²ãŒã
ïŒKonjugatïŒã®åœ¢æ γâã°ãããªã³æº¶æ¶²ïŒmlïŒããçœè³ª56.6mgå«
æïŒã« (a) äŸïŒã«ãã補é ãããã©ããã¯ã¹æžæ¿æ¶² (b) äŸïŒã«ããèªå°äœåãããã©ããã¯ã¹æžæ¿æ¶² (c) äŸïŒã«ããèªå°äœåããã ã (d) äŸïŒã«ããèªå°äœåããã ã å20mlãå ãããã€å®€æž©ã§12æééæãããæ®ç
ããæžæ¿æ¶²ãé å¿åé¢ãããåŒç¶ãäžæŸã¿æ¶²äžã®
éé¢ã®ããçœè³ªã枬å®ãããå®æž¬å€ããã©ããã¯
ã¹ç²åã«çµåãããå²åãèšç®ããããšãã§ã
ããããã«ããã° ããã(a)ã¯Î³âã°ãããªã³ ïŒmgãçµåããŠå«æã ã (b)㯠ã 43mgãçµåããŠå«æã ã (c)㯠ã 15mgãçµåããŠå«æã ã (d)㯠ã 19mgãçµåããŠå«æã äŸ 11 ã©ããã¯ã¹âIgGâã³ã³ãžãŠã²ãŒã äŸ10ã®ããã«ããŠIgGâ溶液ããã³çš®ã ã®ã©ã
ãã¯ã¹æžæ¿æ¶²ããã©ããã¯ã¹âIgGã³ã³ãžãŠã²ãŒ
ãã補é ãããæäœè€åäœåœ¢æã«ãã€ãŠã©ããã¯
ã¹ç²åã«IgGâååãç©èŒãããŠããããšãæ€åº
ãããã 以äžæ¬çºæã«ãã芪氎æ§ã©ããã¯ã¹ç²åã®äœ¿çš
äŸãšããŠã詳现ã«ã¯ãããžã®æT4âè¡æž ããã®
T4âæäœãçšããŠãããã·ã³ïŒT4ïŒãå ç«å®é
ããããã®ãããã³äºéæäœâåé¢æ³ãçšããŠè¡
æž äžã®ãããã¬ãªãããã³ïŒTSHïŒãå®éãã
ããã®ïŒã€ã®èšºæè¬ãèšèŒããã äŸ 12 ãããžã®æT4âè¡æž ã«å¯Ÿãããã€ãªã€ãšããŠ
ã®ãã¢ããªã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬ãŒãã©ããã¯
ã¹ç²åã®äœ¿çšïŒT4âELISAãè¡ãªãããã®èšº
æè¬ ãããã·ã³ïŒT4ïŒãELISAãçšããŠå®éãã
ããã«å ããããžã®æT4âè¡æž ããã®T4âæäœ
ãæ¬çºæã«ãã芪氎æ§ãã¢ããªã°ãªã·ãžã«ã¡ã¿ã¯
ãªã¬ãŒãã©ããã¯ã¹ç²åã«ã該ç²åãäŸïŒãïŒã®
ããããã«ãã€ãŠèªå°äœåãããã€äŸ10ããã³11
ãšåæ§ã«ããŠT4âæäœãšåå¿ãããããšã«ãã€
ãŠå ±æçµåããããããããŠåŸããããœãªããâ
ããšãŒã¹ïŒSolidâFaceïŒâæäœã¯è©Šéšã®ããã®
第ïŒè©Šè¬ã§ããã第ïŒè©Šè¬ãšããŠT4ãèªäœå ¬ç¥
ã®æ¹æ³ã§å¥œé©ãªé µçŽ ãäŸãã°ãã«ãªãã·ããŒãŒ
ïŒPODïŒãŸãã¯Î²âã¬ã©ã¯ãã·ããŒãŒïŒÎ²âGalïŒ
ã§æšèãããããªãã¡çµåããŠé µçŽ ã³ã³ãžãŠã²ãŒ
ãã«ãããé µçŽ ãšããŠãã®äŸã§ã¯Î²âGalã䜿çš
ããã第ïŒè©Šè¬ã¯æªç¥éã®T4ãå«æããè©Šæã§
ããããã€ç¬¬ïŒè©Šè¬ã¯é µçŽ ã³ã³ãžãŠã²ãŒãã®Î²â
Galã®åžžçšã®åºè³ªã§ããã詳现ã«ã¯ãã®äŸã§ã¯ã
ãªã¹âHClâç·©è¡æ¶²ïŒPH7.3ïŒäžã®ãããããšã
ã«âβâã¬ã©ã¯ãã·ãã§ããã è©Šéšã®åçã¯æ¬¡ã®ïŒã€ã®åå¿çµéã«åºã¥ãïŒ ïŒ äžæ¹ã®èŠªæ°Žæ§ã©ããã¯ã¹ç²åã«å ±æçµåãã
T4âæäœãšä»æ¹ã®é µçŽ æšèT4ïŒâé µçŽ ã³ã³ãžãŠ
ã²ãŒãâïŒãšè©Šæäžã«å«ãŸããéé¢ã®T4ãšã®é
ã®å ç«åå¿ããã®åå¿ã§ã¯ãœãªããâããšãŒã¹
âæäœãé µçŽ ã³ã³ãžãŠã²ãŒãããã³è©Šæã®T4
ã®éã«ç«¶åççµåãèµ·ããã ïŒ ïŒ¢ïŒïŒŠâåé¢ïŒïŒ¢ïŒçµåãïŒéé¢ïŒããã
ã¯çµåããé µçŽ ã³ã³ãžãŠã²ãŒã(B)ãšçµåããªã
é µçŽ ã³ã³ãžãŠã²ãŒã(F)ã®åé¢ã§ããããã®åé¢
ã¯æå©ã«é å¿åé¢ãŸãã¯äŸãã°æ°ŽãŸãã¯å¥œé©ãª
ç·©è¡æ¶²ã«å¯Ÿããéæã«ãã€ãŠéæãããã ïŒ é µçŽ ã³ã³ãžãŠã²ãŒããšåžžçšã®ã䜿çšãããé µ
çŽ ã«é¢ããŠç¹ç°çãªåºè³ªãšã®éã«é²è¡ãããã€
æ¯è²æ³ãŸãã¯ä»ã®å ¬ç¥æ¹æ³ã§è¿œè·¡ããããšã®ã§
ããé µçŽ æ€åºåå¿ãé µçŽ æŽ»æ§ã¯äžæŸã¿æ¶²ïŒéé¢
éšåïŒäžã§ããŸãã¯åæžæ¿ãããæ²æŸ±ç©ïŒçµå
éšåïŒäžã§æž¬å®ããããšãã§ããã è©Šéšå®æœ åèšã®ããã«ããŠè£œé ãããã©ããã¯ã¹âæ
T4æžæ¿æ¶²ãæ°ŽãŸãã¯ç·©è¡æ¶²äžã§æ¯ïŒïŒ1000ã§åž
éããããã®æžæ¿æ¶²0.5mlã«çš®ã ã®æ¢ç¥éã®T4â
å«éãæããT4âè¡æž æšäžæº¶æ¶²100ÎŒããã³T4
âβâGalâã³ã³ãžãŠã²ãŒã溶液100ÎŒãå ã
ããåå¿æ··åç©ã宀枩ã§30åææž©ä¿æãããææž©
ä¿æã®éïŒããããäžæã«æ¯çªãããã€åãT4
âæšæºå«éãæããïŒããããåã«æŸçœ®ããã次
ãã§ããããæžæ¿æ¶²ãé å¿åé¢ãããã€ïŒŠâçžã
ååšããäžæŸã¿æ¶²ãåé¢ãããâçžãããªãã¡
ãœãªããâããšãŒã¹æäœã«çµåããT4âβâGal
ã³ã³ãžãŠã²ãŒãã¯æ²æŸ±ç©äžã«ååšãããé µçŽ æŽ»æ§
ã枬å®ããããã«ããã ïœâãããããšãã«âβâã¬ã©ã¯ãã·ãïŒã·ã°ã
ç€ŸïŒ 450mgïŒ å¡©åãããªãŠã 100ããªã¢ã« å¡©åãã°ãã·ãŠã 10ããªã¢ã« ããªã¹ç·©è¡å€ïŒHCl 10ããªã¢ã« ã¡ã«ã«ãããšã¿ããŒã« 0.4vïŒïœïŒ ããæããPH7.3ã®éå°ã®åºè³ªæº¶æ¶²ã«å ãããã€
å ¬ç¥æ¹æ³ã§æ³¢é·405nïœã§åžå 床ã枬å®ãããå€
éšã®æ©æ¢°çãªæ··åãããªãå Žåã«æžæ¿ç¶æ ã§ä¿æ
ãããã©ããã¯ã¹ç²åãçŽ11ïŒ æžå°ããã·ã°ãã«
ãäžããããšã瀺ãããã ãã®ããã«ããŠT4âæ€éæ²ç·ã枬å®ããåŸã
åŒç¶ãåæ§ã«ããŠT4âæšæºè¡æž 100ÎŒã®ä»£ãã
ã«æªç¥éã®T4å«éã®è©Šæãããã100ÎŒã䜿çš
ãããã€åæžæ¿åŸã®ïŒ¢âçžã®åžå 床ãåºè³ªæº¶æ¶²äž
ã§æž¬å®ããããšã«ããå®éãè¡ãªã€ãã 芪氎æ§ã©ããã¯ã¹ç²åãæäœããã³æåã®ãã€
ãªã€ãšããŠããããŠå¥œé©ã§ããããã€ãããã®å
ç«åå¿æ§ã®æãªããªãããšãèªãããããããã€
ãŠèŠªæ°Žæ§ã©ããã¯ã¹ç²åã¯ãœãªããâããšãŒã¹â
é µçŽ å ç«è©Šéšã§ãã€ãªã€ãšããŠæå©ã«äœ¿çšããã
ãšãã§ãããæŽã«ç·©è¡å€æ¡ä»¶ã«ãã芪氎æ§ã©ãã
ã¯ã¹ç²åãé·æéã«ããã€ãŠæžæ¿ç¶æ ãä¿æãã
ãããã€ãŠç²åã®å¯åºŠãã»ãŒïŒã«çããããšãèª
ããããããã®äžã«æ¬çºæã«ãã芪氎æ§ã©ããã¯
ã¹ç²åã¯å ç«åå¿æ§ãæãªããã«è¯å¥œã«é å¿åé¢
å¯èœã§ããããã€åæžæ¿å¯èœã§ããã äŸ 13 ãããã¬ãªãããã³ïŒTSHïŒãå®éãããã
ã®é µçŽ å ç«å®éïŒEIAïŒ ããè¡æž äžã®TSHã®æž¬å®ã¯ç²ç¶è ºçŸç ã®èšºæ
ã§èããéèŠã§ãããåºç€TSHæ¿åºŠã®èããäž
æã§ïŒæ¬¡ç²ç¶è ºæ©èœæžåŒ±ãèªããããããã®ä»è¡
æž äžã®TSHåºç€å€0.5ã3ÎŒUïŒmlãTRHïŒåºæ¿ã
ã«ã¢ã³æŸåºå åïŒã§åºæ¿åŸã«äžæããªãå Žåã«ç²
ç¶è ºæ©èœæžåŒ±ã¯ç¢ºå®ã«ããåŸãªããããã«å¯ŸããŠ
TSHå€ãå°ãªããšã2.5ÎŒUïŒmlãããã25ÎŒUïŒ
ml以äžã§äžæããå Žåã«ã¯ç²ç¶è ºç©è³ªä»£è¬ã¯é«ã
確çã§æãªãããŠããªãã25ÎŒUïŒmlãå ãã«äž
åã€ãåºç€å€ã®äžæã¯æœåšçãªçç¶çºçŸåã®ç²ç¶
è ºæ©èœæžåŒ±ãæšæž¬ããããšãã§ãããæ¢ã«TSH
ã®é µçŽ å ç«å®éã¯å ¬ç¥ã§ãããâã¯ãªãã«ã»ãã
ã«ã»ã¢ã¯ã¿ïŒClinica Chemica ActaïŒâã第67
å·»ã263ã268é ïŒ1976幎ïŒïŒâãšã³ãã€ãŒã¡ã»ã©ã
ã«ãã»ã€ã ãã¢ãã»ã€ã»ãªãã»ãã«ã¢ã³ãºã»ã¢ã³
ãã»ãã©ãã°ã¹ïŒenzyme labelled
immunoassay of hormones and drugsâã327ã
337é ãS.B.PalãWalter de Gruyterããã«ãªã³
ããã³N.Y.ïŒ1978幎ïŒïŒâã¢ããªãŠãŒãã«ã«ã»ããª
ã±ãã¹ããªïŒAnalytical BiochemistryïŒâ第96
å·»ã419ã425é ïŒ1979幎ïŒããããããããã®å ¬ç¥
ã®æž¬å®æ³ã¯ããããŠé·ãææž©ä¿ææéïŒïŒæ¥ãŸ
ã§ïŒãå¿ èŠãšããéæã§ã¯ãªãïŒTSH5ÎŒUïŒmlïŒ
ãŸãã¯é«äŸ¡ãªæž¬å®è£ 眮ïŒè¢å 枬å®è£ 眮ãŸãã¯çºå
枬å®è£ 眮ïŒãšåæãšãããã®éãã®ä»ã«ãããã
æ··åããããã®è£ 眮ãå¿ èŠã§ããã æ¬çºæã«ãã芪氎æ§ã©ããã¯ã¹ç²åã®äœ¿çšã¯ïŒ
1/2æ¥ã«ãããªãå šææž©ä¿ææéã§äºéæäœåé¢
æè¡ã«ããTSHã®æž¬å æ³ã«ãã枬å®ãå¯èœã«ã
ãããã®é第ïŒã®æäœãæ¬çºæã«ãã芪氎æ§ã©ã
ãã¯ã¹ç²åã«å ±æçµåãããã次ãã§çµåããã
é µçŽ æŽ»æ§ãïŒïŒŠâåé¢ã«ãã枬å®ãããã©ãã
ã¯ã¹ç²åã¯æ°Žã®å¯åºŠãããèããã¯é«ããªãå¯åºŠ
ãæããŠããã®ã§ãã©ããã¯ã¹ç²åã¯é µçŽ åå¿ã®
éãæžæ¿ç¶æ ã§ãããããã«ããåžžçšã®å Žåãç
ç¥ããããæäœã®é«ãè² è·å¯èœæ§ã®ããã«å¯èœã§
ããããããŠåžéãããã©ããã¯ã¹ç²åã䜿çšã
ãå Žåã«ã¯é µçŽ åå¿çµäºåŸã®ç²åã®é å¿åé¢ãç
ç¥ãããããããšããã®ãæžæ¿æ¶²ãééããŠæž¬å
ã§ããããã§ããã å ç«åŠçè©Šéšæ¹æ³ã§äžè¬ã«äœ¿çšãããã©ããã¯
ã¹ãšã¯ç°ãªãæäœãè² è·ããããæ¬çºæã«ãã芪
æ°Žæ§ããªã°ãªã·ãžã«ã¡ã¿ã¯ãªã¬ãŒãç²åã¯é å¿å
é¢åŸå®¹æã«åæžæ¿ãããããšãã§ãããåãçç±
ããé µçŽ ã§æšèãããæåã®ããããŠå°ããéç¹
ç°çåžçã瀺ãããïŒç¬¬ïŒæäœã®äžåšã§ã®çµåã
ãã掻æ§ïŒã è©Šéšå®æœ TSHâæšæºïŒTSHäžå«è¡æž äžã®åœéåç §èª¿å€
MRC68ïŒ38ïŒ0.2mlãïŒïŒ150000ã§æ°ŽãŸãã¯å¥œé©
ãªç·©è¡æº¶æ¶²ã§åžéãããèªäœå ¬ç¥ã®ãäŸãã°ã¢ã«
ã¢ããã®æTSHâæè¡æž 0.1mlãšãšãã«ææž©ä¿æ
ããã12æéåŸã°ã«ã³ãŒã¹ãªãã·ããŒãŒïŒGODïŒ
ã«å ±æçµåããTSHïŒTSHçŽ1.5Ã10-9ïœã«çžåœïŒ
ããæãé µçŽ ã³ã³ãžãŠã²ãŒãã®æº¶æ¶²0.1mlã第ïŒ
å·¥çšã®æ··åç©ã«ããããã§æ·»å ããããã®æ··åç©
ã«æŽã«12æéåŸã©ããã¯ã¹æžæ¿æ¶²0.1mlãããã
ãã§æ·»å ããã該æžæ¿æ¶²ã¯ã¡ã¿ã¯ãªã¬ãŒãã©ãã
ã¯ã¹0.1ãïŒmgïŒmlãå«æãããã®éäŸ11ã«èšèŒ
ãããŠããããã«ä¹Ÿç¥ã©ããã¯ã¹ç²å1000mgã«ã€
ããã¢ã«ã¢ããâIgGã«å¯Ÿããã€ã®ã®æè¡æž ãã
åŸãããå ç«ã°ãããªã³ãã©ã¯ã·ãšã³ã®ããçœè³ª
ïŒã150mgãå ãããã€ããããŠèŠªæ°Žæ§ã©ããã¯
ã¹ç²åã«å ±æçµåããããïŒæéåŸé å¿åé¢ãã
ãã€ã©ããã¯ã¹ç²åã®æ²æŸ±ç©ã奜é©ãªç·©è¡æº¶æ¶²ïŒ
mlã§æŽããããã«ããã©ããã¯ã¹ç²åã¯åæžæ¿ã
ãããåŒç¶ãæ¹ããŠæ°åºŠé å¿åé¢ãããã€æŽæµã
ããäžæŸã¿æ¶²ãæ£ãŠãã åãããã«GODã®åºè³ªæº¶æ¶²ïŒmlãããããã§
å ¥ãããã€çæéæ¯çªããããã®åŸå°ãªããšãïŒ
æéã©ããã¯ã¹ç²åã¯åäžã«æžæ¿ããããŸãŸã§ã
ãã次ãã§æžæ¿æ¶²ãç®çãã¯ãããã«å ¥ãããã€
405nïœã§åžå 床ã枬å®ãããååžå 床ããåºè³ª
ç²æ€å€L1ãåŒããL1ã¯ãæTSHâæè¡æž ãšTSH
âGODãšã®æ··åç©ã«æ·»å ãããåèšã®ã©ããã¯
ã¹æžæ¿æ¶²ãšåãç©è³ªãè² è·ãããã©ããã¯ã¹ç²å
ãå«ãåºè³ªæº¶æ¶²ïŒmlã®åžå 床ã§ããã ããããŠæ±ããããåžå 床ãçš®ã ã®TSHæšæº
æ¿åºŠã«é¢ããŠèšé²ããããã®æ€éæ²ç·ãçšããŠèš
åºè©Šæäžã®æªç¥å«éã®TSHã®æ¿åºŠã枬å®ããåž
å 床ã«åºã¥ããŠèªã¿åãã 奜é©ãªç·©è¡æº¶æ¶²ãšããŠæå©ã«EDTA0.005ã¢ã«ã
ãŠã·è¡æž ã¢ã«ããã³0.1ïŒ äžŠã³ã«NaCl0.15ã¢ã«ã
å«ã0.04Mâãã¹ããšãŒã溶液ïŒPH7.4ïŒã䜿çš
ããã GODâåºè³ªæº¶æ¶²ãšããŠæå©ã«ã°ã«ã³ãŒã¹ïŒ
ïœïŒ100mlãïŒïŒ2â²âã¢ãžãâãžâãïŒâãšãã«â
ãã³ãºãã¢ãŸãã³âã¹ã«ãã³é ž(6)ãïŒABTSïŒ
100mgïŒ100mlããã«ãªãã·ããŒãŒïŒPODïŒïŒ
mgïŒ100mlã0.05Mâãã¹ããšãŒãç·©è¡æ¶²ïŒPH
5.6ïŒãå«ã氎溶液ã䜿çšããã æ¯èŒã®ããã«ïŒã€ã®è¡æž è©Šæã®TSHå«éãå
èšEIA(A)䞊ã³ã«å ¬ç¥ã®äºéæäœâRIA(B)ã§æž¬å®ã
ãã次衚ã«ç€ºãéããããã枬å®å€ã¯è¯ãäžèŽã
ãïŒ (A) (B) è¡æž ïŒ 11.2ÎŒUïŒml 12.5ÎŒUïŒml ïŒ 7.3ÎŒUïŒml 7.1ÎŒUïŒml è¡æž ïŒ 3.8ÎŒUïŒml 4.5ÎŒUïŒml åèšã®TSHâ枬å®ããããæ¬çºæã«ãã芪氎
æ§ã©ããã¯ã¹ç²åãçç©åŠçããã³ïŒãŸãã¯å ç«
åŠçã«æŽ»æ§ãªç©è³ªãç¹ã«æäœã®ãã€ãªã€ãšããŠã
ãããŠå¥œé©ã§ããããšãåŸãããã éç¹ç°ççµåã®æž¬å® TSHæšæºè©Šæãåèšã®è©Šéšå®æœã®é ç®ã§èšèŒ
ãããããã«ããŠåŠçãïŒè©ŠæïŒããã€ã»ãšã
ã©è©Šæãšåãåå¿ã«ãããããåæ§ã®è©ŠæïŒè©Š
æïŒãšæ¯èŒãããæTSHâæè¡æž ã®ã¿ã¯çã
ããè©ŠæãšïŒ€ã®æžæ¿æ¶²ã§æž¬å®ãããåžå 床ã®æ¯
èŒã¯éç¹ç°ççµåã1.5ïŒ ãããå°ããããšã瀺
ãã ãè¡šã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ ãã€ãªã€ãšããŠæ°Žã«é£æº¶æ§ã®ã¢ãããŒã§ãã
ååäžã«å°ãªããšãïŒåã®éåå¯èœãªïŒ£ïŒïŒ£âäº
éçµåãæãããšããã·ãã®ãã¢ããªããŒãŸãã¯
ã³ããªããŒããæã芪氎æ§ã©ããã¯ã¹ç²åããã³
ãã®ãã€ãªã€ã«çŽæ¥ãŸãã¯âããªããžâãšããŠã®
çµåå€ãä»ããŠå ±æçµåããçç©åŠçã«ãã€ïŒãŸ
ãã¯å ç«åŠçã«æŽ»æ§ãªç©è³ªãå«æãããããã®
éã芪氎æ§ã©ããã¯ã¹ç²åã氎溶æ§ã®ã©ãžã«ã«åœ¢
ææ§éå§å€ã®ååšã§ããããä¹³åå€ãå®å®å€ãæ·»
å ããã«ãšãã«ãžãšã³éåã«ãã€ãŠè£œé å¯èœã§ã
ãããšãç¹åŸŽãšããã蚺æè¬ã ïŒ çç©åŠçã«ãã€ïŒãŸãã¯å ç«åŠçã«æŽ»æ§ãªç©
質ãšããŠãããããããçœè³ªãé µçŽ ããã«ã¢ã³ã
ãã¿ãã³ãæåãæäœãŸãã¯åŸ®çç©ãå«æããã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®èšºæè¬ã ïŒ ãããã·ã³æž¬å®ã®ããã®èšºæè¬ãšããŠçç©åŠ
çã«ãã€ïŒãŸãã¯å ç«åŠçã«æŽ»æ§ãªç©è³ªãšããŠã
ããã·ã³æäœãå«æãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
èšèŒã®èšºæè¬ã ïŒ ãããã¬ãªãããã³æž¬å®ã®èšºæè¬ãšããŠçç©
åŠçã«ãã€ïŒãŸãã¯å ç«åŠçã«æŽ»æ§ãªç©è³ªãšããŠ
ããâãã¬ãªãããã³æäœãå«æãããç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒé èšèŒã®èšºæè¬ã
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3048883.6 | 1980-12-23 | ||
| DE19803048883 DE3048883A1 (de) | 1980-12-23 | 1980-12-23 | Hydrophile latexpartikel, verfahren zu deren herstellung und deren verwendung |
| CS9235-80 | 1980-12-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59116548A JPS59116548A (ja) | 1984-07-05 |
| JPH028271B2 true JPH028271B2 (ja) | 1990-02-23 |
Family
ID=6120185
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56207275A Expired JPS6043361B2 (ja) | 1980-12-23 | 1981-12-23 | 芪氎æ§ã©ããã¯ã¹ç²åã®è£œæ³ |
| JP58230705A Granted JPS59116548A (ja) | 1980-12-23 | 1983-12-08 | 芪氎æ§ã©ããã¯ã¹ç²åãå«æãã蚺æè¬ |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56207275A Expired JPS6043361B2 (ja) | 1980-12-23 | 1981-12-23 | 芪氎æ§ã©ããã¯ã¹ç²åã®è£œæ³ |
Country Status (2)
| Country | Link |
|---|---|
| JP (2) | JPS6043361B2 (ja) |
| DE (1) | DE3048883A1 (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58185604A (ja) * | 1982-04-26 | 1983-10-29 | Tokuyama Soda Co Ltd | ããªã¡ã¿ã¯ãªã«é žã°ãªã·ãžã«ã©ããã¯ã¹ã®è£œé æ¹æ³ |
| JPS59182804A (ja) * | 1983-04-01 | 1984-10-17 | Toray Ind Inc | åå¿æ§åŸ®ç²åããã³ãã®è£œé æ³ |
| JPS59204601A (ja) * | 1983-05-09 | 1984-11-20 | Unitika Ltd | çç掻æ§ãæããæ圢äœã®è£œé æ¹æ³ |
| DE3318184A1 (de) * | 1983-05-19 | 1984-11-22 | Boehringer Mannheim Gmbh, 6800 Mannheim | Traeger zur beschichtung mit immunologisch aktivem material |
| JPS59219380A (ja) * | 1983-05-27 | 1984-12-10 | Nippon Mektron Ltd | æ¥æ°Žæ¥æ²¹å€ãšãã«ãžãšã³ã®è£œé æ³ |
| KR860001409B1 (ko) * | 1983-06-10 | 1986-09-23 | ëíŒìì€ë ê³ ì€êµì€ ê°ë¶ìëŒê°ìŽì€ | ë¹ìŽëì íŽëŠ¬ëšžì ì ì¡°ë² |
| JPH0713641B2 (ja) * | 1984-05-07 | 1995-02-15 | æ ªåŒäŒç€Ÿãã¯ã€ã | 蚺æçšè©Šè¬ã®è£œé æ¹æ³ |
| DE3530312A1 (de) * | 1985-08-24 | 1987-02-26 | Guenther Dr Sawatzki | Traeger fuer die photometrische immunspezifische bestimmung von antigenen oder antikoerpern, verfahren zu ihrer herstellung und verwendung |
| GB2407500A (en) * | 2003-11-03 | 2005-05-04 | Ist Superiore Sanita | Use of microparticles for antigen delivery |
| US7465765B2 (en) * | 2004-09-27 | 2008-12-16 | Hewlett-Packard Development Company, L.P. | Latex particulates with epoxide functional groups |
| JP4993081B2 (ja) * | 2007-02-28 | 2012-08-08 | ïœïœæ ªåŒäŒç€Ÿ | èçœè³ªåºå®åç£æ§ç²åããã³ãã®è£œé æ¹æ³ |
| WO2008111599A1 (ja) * | 2007-03-12 | 2008-09-18 | Jsr Corporation | çäœé¢é£ç©è³ªã®æ€åºæ¹æ³ |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5428816A (en) * | 1977-08-03 | 1979-03-03 | Hoffmann La Roche | Immunological diagnostic reagent |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2841033A1 (de) * | 1978-09-21 | 1980-04-03 | Bayer Ag | Verfahren zur herstellung waessriger polymerisatdispersionen |
-
1980
- 1980-12-23 DE DE19803048883 patent/DE3048883A1/de not_active Ceased
-
1981
- 1981-12-23 JP JP56207275A patent/JPS6043361B2/ja not_active Expired
-
1983
- 1983-12-08 JP JP58230705A patent/JPS59116548A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5428816A (en) * | 1977-08-03 | 1979-03-03 | Hoffmann La Roche | Immunological diagnostic reagent |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS57135801A (en) | 1982-08-21 |
| JPS59116548A (ja) | 1984-07-05 |
| DE3048883A1 (de) | 1982-07-15 |
| JPS6043361B2 (ja) | 1985-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4415700A (en) | Hydrophilic latex particles and use thereof | |
| JP2536995B2 (ja) | é µçŽ åºå®æ³ | |
| JP2701949B2 (ja) | è©Šéšæ¹æ³ããã³ãã®ããã®è©Šè¬ããã | |
| EP0462644B1 (en) | Biologically active reagents prepared from carboxy-containing polymer, analytical element and methods of use | |
| EP0019741B1 (de) | Latex-Reagenz, Verfahren zu seiner Herstellung, seine Verwendung und ein das Reagenz enthaltendes Mittel | |
| JPS5896616A (ja) | æåãæäœãŸãã¯ãããã³ã®æ€åºè©Šè¬ããã³ããã«äœ¿çšããã©ããã¯ã¹äžŠã³ã«ãããã®è£œæ³ | |
| JPS6315551B2 (ja) | ||
| JPH028271B2 (ja) | ||
| JPH0810224B2 (ja) | çç掻æ§ç©è³ªåºå®åçšã©ããã¯ã¹åã³ãã®ã©ããã¯ã¹ãçšããã©ããã¯ã¹è©Šè¬ | |
| CN114555650B (zh) | é¢ç²ä»¥åå¶é é¢ç²çæ¹æ³ | |
| EP0372413B1 (de) | Mittel fÃŒr immunchemische Tests, carboxylgruppenhaltige Polymere enthaltend | |
| JP2016031250A (ja) | æšçã¿ã³ãã¯è³ªã®æž¬å®è©Šè¬ããã³è©²è©Šè¬ãçšãã枬å®æ¹æ³ | |
| JPS6243501B2 (ja) | ||
| JPH01127958A (ja) | ã«ã«ãã¢ã€ã«ãªããŠã ååç©ãçšããŠããªããŒç²åã«ååç©ãçµåãããæ¹æ³ | |
| JPS6253773B2 (ja) | ||
| JP3618797B2 (ja) | å ç«æž¬å®æ³ | |
| JP3464357B2 (ja) | å ç«åŠçåéåå¿è©Šè¬ã®è£œé æ¹æ³ | |
| JPS59182804A (ja) | åå¿æ§åŸ®ç²åããã³ãã®è£œé æ³ | |
| JPS6366464A (ja) | 蚺æè©Šè¬çšæ äœã©ããã¯ã¹ | |
| JPH03103195A (ja) | è¡æ åã³ååºäº¢é²ç¶æ ã®èšºæåã³æ€æ»ã®ããã®çç©åŠçè©Šæããã®ïœâãã€ããŒã®çŽæ¥ååŠçµåçæ¹æ³ | |
| JPS5919856A (ja) | å ç«åŠç掻æ§ç©è³ªåºå®åçšæ äœåŸ®ç²å | |
| HU191603B (hu) | Diagnosztikai reagens és eljárás hidrofil latexrészecskéket tartalmazó szuszpenziÅk elÅállÃtására | |
| JP4104219B2 (ja) | æãã¬ãããŒãæäœæž¬å®è©Šè¬ã®è£œé æ¹æ³ã枬å®è©Šè¬åã³æž¬å®æ¹æ³ | |
| JPS6315552B2 (ja) | ||
| JPH08278308A (ja) | å ç«æž¬å®æ³ |